Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Yves Agid

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Anatomy

Chemicals & Drugs

Living Beings

Rats

Concepts & Ideas

Procedures

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Ribeiro Maria-João; Thobois Stéphane; Lohmann Ebba; du Montcel Sophie Tezenas; Lesage Suzanne; Pelissolo Antoine; Dubois Bruno; Mallet Luc; Pollak Pierre; Agid Yves; Broussolle Emmanuel; Brice Alexis; Remy Philippe;
A multitracer dopaminergic PET study of young-onset parkinsonian patients with and without parkin gene mutations.
Vidailhet Marie; Yelnik Jerome; Lagrange Christelle; Fraix Valerie; Grabli David; Thobois Stephane; Burbaud Pierre; Welter Marie-Laure; Xie-Brustolin Jin; Braga Maria-Clara Coelho; Ardouin Claire; Czernecki Virginie; Klinger Hélène; Chabardes Stephan; Seigneuret Eric; Mertens Patrick; Cuny Emmanuel; Navarro Soledad; Cornu Philippe; Benabid Alim-Louis; Le Bas Jean-Francois; Dormont Didier; Hermier Marc; Dujardin Kathy; Blond Serge; Krystkowiak Pierre; Destée Alain; Bardinet Eric; Agid Yves; Krack Paul; Broussolle Emmanuel; Pollak Pierre;
Bilateral pallidal deep brain stimulation for the treatment of patients with dystonia-choreoathetosis cerebral palsy: a prospective pilot study.
Volkmann Jens; Albanese Alberto; Kulisevsky Jaime; Tornqvist Aana-Lena; Houeto Jean-Luc; Pidoux Bernard; Bonnet Anne-Marie; Mendes Alexandre; Benabid Alim-Louis; Fraix Valerie; Van Blercom Nadege; Xie Jing; Obeso José; Rodriguez-Oroz Maria Cruz; Guridi Jurge; Schnitzler Alfons; Timmermann Lars; Gironell Alexandre A; Molet Juan; Pascual-Sedano Benta; Rehncrona Stig; Moro Elena; Lang Anthony C; Lozano Andres M; Bentivoglio Anna Rita; Scerrati Massimo; Contarino Maria Fiorella; Romito Luigi; Janssens Marc; Agid Yves
Long-term effects of pallidal or subthalamic deep brain stimulation on quality of life in Parkinson's disease.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Yves Agid (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Ribeiro Maria-João; Thobois Stéphane; Lohmann Ebba; du Montcel Sophie Tezenas; Lesage Suzanne; Pelissolo Antoine; Dubois Bruno; Mallet Luc; Pollak Pierre; Agid Yves; Broussolle Emmanuel; Brice Alexis; Remy Philippe;
A multitracer dopaminergic PET study of young-onset parkinsonian patients with and without parkin gene mutations.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2009;50(8):1244-50.
2009: Vidailhet Marie; Yelnik Jerome; Lagrange Christelle; Fraix Valerie; Grabli David; Thobois Stephane; Burbaud Pierre; Welter Marie-Laure; Xie-Brustolin Jin; Braga Maria-Clara Coelho; Ardouin Claire; Czernecki Virginie; Klinger Hélène; Chabardes Stephan; Seigneuret Eric; Mertens Patrick; Cuny Emmanuel; Navarro Soledad; Cornu Philippe; Benabid Alim-Louis; Le Bas Jean-Francois; Dormont Didier; Hermier Marc; Dujardin Kathy; Blond Serge; Krystkowiak Pierre; Destée Alain; Bardinet Eric; Agid Yves; Krack Paul; Broussolle Emmanuel; Pollak Pierre;
Bilateral pallidal deep brain stimulation for the treatment of patients with dystonia-choreoathetosis cerebral palsy: a prospective pilot study.
Lancet neurology 2009;8(8):709-17.
2009: Volkmann Jens; Albanese Alberto; Kulisevsky Jaime; Tornqvist Aana-Lena; Houeto Jean-Luc; Pidoux Bernard; Bonnet Anne-Marie; Mendes Alexandre; Benabid Alim-Louis; Fraix Valerie; Van Blercom Nadege; Xie Jing; Obeso José; Rodriguez-Oroz Maria Cruz; Guridi Jurge; Schnitzler Alfons; Timmermann Lars; Gironell Alexandre A; Molet Juan; Pascual-Sedano Benta; Rehncrona Stig; Moro Elena; Lang Anthony C; Lozano Andres M; Bentivoglio Anna Rita; Scerrati Massimo; Contarino Maria Fiorella; Romito Luigi; Janssens Marc; Agid Yves
Long-term effects of pallidal or subthalamic deep brain stimulation on quality of life in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2009;24(8):1154-61.
2009: Lohmann Ebba; Leclere Laurence; De Anna Francesca; Lesage Suzanne; Dubois Bruno; Agid Yves; Dürr Alexandra; Brice Alexis;
A clinical, neuropsychological and olfactory evaluation of a large family with LRRK2 mutations.
Parkinsonism & related disorders 2009;15(4):273-6.
2009: Bardinet Eric; Bhattacharjee Manik; Dormont Didier; Pidoux Bernard; Malandain Grégoire; Schüpbach Michael; Ayache Nicholas; Cornu Philippe; Agid Yves; Yelnik Jérôme
A three-dimensional histological atlas of the human basal ganglia. II. Atlas deformation strategy and evaluation in deep brain stimulation for Parkinson disease.
Journal of neurosurgery 2009;110(2):208-19.
2009: Payoux Pierre; Remy Philippe; Miloudi Malika; Houeto Jean-Luc; Stadler Claudio; Bejjani Boulos-Paul; Yelnik Jérome; Samson Yves; Rascol Olivier; Agid Yves; Damier Philippe
Contrasting changes in cortical activation induced by acute high-frequency stimulation within the globus pallidus in Parkinson's disease.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2009;29(2):235-43.
2009: Ibáñez Pablo; Lesage Suzanne; Janin Sabine; Lohmann Ebba; Durif Frank; Destée Alain; Bonnet Anne-Marie; Brefel-Courbon Christine; Heath Simon; Zelenika Diana; Agid Yves; Dürr Alexandra; Brice Alexis;
Alpha-synuclein gene rearrangements in dominantly inherited parkinsonism: frequency, phenotype, and mechanisms.
Archives of neurology 2009;66(1):102-8.
2009: Bensimon Gilbert; Ludolph Albert; Agid Yves; Vidailhet Marie; Payan Christine; Leigh P Nigel;
Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS study.
Brain : a journal of neurology 2009;132(Pt 1):156-71.
2009: Chastan N; Westby G W M; Yelnik J; Bardinet E; Do M C; Agid Y; Welter M L
Effects of nigral stimulation on locomotion and postural stability in patients with Parkinson's disease.
Brain : a journal of neurology 2009;132(Pt 1):172-84.
2009: Lohmann E; Thobois S; Lesage S; Broussolle E; du Montcel S Tezenas; Ribeiro M-J; Remy P; Pelissolo A; Dubois B; Mallet L; Pollak P; Agid Y; Brice A;
A multidisciplinary study of patients with early-onset PD with and without parkin mutations.
Neurology 2009;72(2):110-6.
2009: Chastan Nathalie; Do Manh Cuong; Bonneville Fabrice; Torny Frédéric; Bloch Frédéric; Westby G W Max; Dormont Didier; Agid Yves; Welter Marie-Laure
Gait and balance disorders in Parkinson's disease: impaired active braking of the fall of centre of gravity.
Movement disorders : official journal of the Movement Disorder Society 2009;24(2):188-95.
2009: El Otmani H; Jodoin N; Yaici S; Welter M-L; Bonnet A-M; Navarro S; Pidoux B; Dormont D; Cornu P; Agid Y
[Can subthalamic nucleus stimulation reveal parkinsonian rest tremor?]
Revue neurologique 2009;165(1):81-5.
2009: Al-Chalabi Ammar; Dürr Alexandra; Wood Nicholas W; Parkinson Michael H; Camuzat Agnes; Hulot Jean-Sébastien; Morrison Karen E; Renton Alan; Sussmuth Sigurd D; Landwehrmeyer Bernhard G; Ludolph Albert; Agid Yves; Brice Alexis; Leigh P Nigel; Bensimon Gilbert;
Genetic variants of the alpha-synuclein gene SNCA are associated with multiple system atrophy.
PloS one 2009;4(9):e7114.
2008: Mallet Luc; Polosan Mircea; Jaafari Nematollah; Baup Nicolas; Welter Marie-Laure; Fontaine Denys; du Montcel Sophie Tezenas; Yelnik Jérôme; Chéreau Isabelle; Arbus Christophe; Raoul Sylvie; Aouizerate Bruno; Damier Philippe; Chabardès Stephan; Czernecki Virginie; Ardouin Claire; Krebs Marie-Odile; Bardinet Eric; Chaynes Patrick; Burbaud Pierre; Cornu Philippe; Derost Philippe; Bougerol Thierry; Bataille Benoit; Mattei Vianney; Dormont Didier; Devaux Bertrand; Vérin Marc; Houeto Jean-Luc; Pollak Pierre; Benabid Alim-Louis; Agid Yves; Krack Paul; Millet Bruno; Pelissolo Antoine;
Subthalamic nucleus stimulation in severe obsessive-compulsive disorder.
The New England journal of medicine 2008;359(20):2121-34.
2008: Bonneville Fabrice; Bloch Frédéric; Kurys Ewa; du Montcel Sophie Tezenas; Welter Marie-Laure; Bonnet Anne-Marie; Agid Yves; Dormont Didier; Houeto Jean-Luc
Camptocormia and Parkinson's disease: MR imaging.
European radiology 2008;18(8):1710-9.
2008: Welter Marie-Laure; Mallet Luc; Houeto Jean-Luc; Karachi Carine; Czernecki Virginie; Cornu Philippe; Navarro Soledad; Pidoux Bernard; Dormont Didier; Bardinet Eric; Yelnik Jérôme; Damier Philippe; Agid Yves
Internal pallidal and thalamic stimulation in patients with Tourette syndrome.
Archives of neurology 2008;65(7):952-7.
2008: Sedel F; Saudubray J-M; Roze E; Agid Y; Vidailhet M
Movement disorders and inborn errors of metabolism in adults: a diagnostic approach.
Journal of inherited metabolic disease 2008;31(3):308-18.
2008: Czernecki Virginie; Schüpbach Michael; Yaici Sadek; Lévy Richard; Bardinet Eric; Yelnik Jérôme; Dubois Bruno; Agid Yves
Apathy following subthalamic stimulation in Parkinson disease: a dopamine responsive symptom.
Movement disorders : official journal of the Movement Disorder Society 2008;23(7):964-9.
2008: Frédéric M Y; Clot F; Cif L; Blanchard A; Dürr A; Vuillaume I; Lesca G; Kreisler A; Davin C; Besnard T; Rousset F; Thorel D; Saquet C; Mechin D; Ozelius L; Agid Y; Barroso B; Chabrol B; Chan V; Clanet M; Coubes C; Destee A; Nguyen K; Vial C; Vidailhet M; Xie J; Sablonniere B; Calender A; Brice A; Roubertie A; Coubes P; Claustres M; Tuffery-Giraud S; Collod-Beroud G
Is the early-onset torsion dystonia (EOTD) linked to TOR1A gene as frequent as expected in France?
Neurogenetics 2008;9(2):143-50.
2008: Lohmann Ebba; Welter Marie-Laure; Fraix Valérie; Krack Paul; Lesage Suzanne; Laine Sophie; Tanguy Marie-Laure; Houeto Jean-Luc; Mesnage Valérie; Pollak Pierre; Durr Alexandra; Agid Yves; Brice Alexis;
Are parkin patients particularly suited for deep-brain stimulation?
Movement disorders : official journal of the Movement Disorder Society 2008;23(5):740-3.
2008: Schüpbach W M Michael; Agid Yves
Psychosocial adjustment after deep brain stimulation in Parkinson's disease.
Nature clinical practice. Neurology 2008;4(2):58-9.
2008: Jedynak C P; Youssov K; Apartis E; Welter M-L; Willer J-C; Agid Y
[Dystonia, tremor and repetitive instrumental use]
Revue neurologique 2008;164(1):53-60.
2008: Blomstedt Patric; Hariz Marwan I; Lees Andrew; Silberstein Paul; Limousin Patricia; Yelnik Jérôme; Agid Yves
Acute severe depression induced by intraoperative stimulation of the substantia nigra: a case report.
Parkinsonism & related disorders 2008;14(3):253-6.
2007: Corvol Jean-Christophe; Anzouan-Kacou Jean-Baptiste; Fauveau Elodie; Bonnet Anne-Marie; Lebrun-Vignes Bénédicte; Girault Camille; Agid Yves; Lechat Philippe; Isnard Richard; Lacomblez Lucette
Heart valve regurgitation, pergolide use, and parkinson disease: an observational study and meta-analysis.
Archives of neurology 2007;64(12):1721-6.
2007: Vercueil Laurent; Houeto Jean Luc; Krystkowiak Pierre; Lagrange Christelle; Cassim François; Benazzouz Abdelhamid; Pidoux Bernard; Destée Alain; Agid Yves; Cornu Philippe; Blond Serge; Benabid Alim Louis; Pollak Pierre; Vidailhet Marie;
Effects of pulse width variations in pallidal stimulation for primary generalized dystonia.
Journal of neurology 2007;254(11):1533-7.
2007: Houeto Jean-Luc; Yelnik Jérôme; Bardinet Eric; Vercueil Laurent; Krystkowiak Pierre; Mesnage Valérie; Lagrange Christelle; Dormont Didier; Le Bas Jean-François; Pruvo Jean-Pierre; Tezenas du Moncel Sophie; Pollak Pierre; Agid Yves; Destée Alain; Vidailhet Marie;
Acute deep-brain stimulation of the internal and external globus pallidus in primary dystonia: functional mapping of the pallidum.
Archives of neurology 2007;64(9):1281-6.
2007: Welter Marie-Laure; Do Manh Cuong; Chastan Nathalie; Torny Frédéric; Bloch Frédéric; du Montcel Sophie Tézenas; Agid Yves
Control of vertical components of gait during initiation of walking in normal adults and patients with progressive supranuclear palsy.
Gait & posture 2007;26(3):393-9.
2007: Mallet Luc; Schüpbach Michael; N'Diaye Karim; Remy Philippe; Bardinet Eric; Czernecki Virginie; Welter Marie-Laure; Pelissolo Antoine; Ruberg Merle; Agid Yves; Yelnik Jérôme
Stimulation of subterritories of the subthalamic nucleus reveals its role in the integration of the emotional and motor aspects of behavior.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(25):10661-6.
2007: Maltête D; Jodoin N; Karachi C; Houeto J L; Navarro S; Cornu P; Agid Y; Welter M L
Subthalamic stimulation and neuronal activity in the substantia nigra in Parkinson's disease.
Journal of neurophysiology 2007;97(6):4017-22.
2007: Lesage Suzanne; Janin Sabine; Lohmann Ebba; Leutenegger Anne-Louise; Leclere Laurence; Viallet François; Pollak Pierre; Durif Franck; Thobois Stéphane; Layet Valérie; Vidailhet Marie; Agid Yves; Dürr Alexandra; Brice Alexis; Bonnet Anne-Marie; Borg Michel; Broussolle Emmanuel; Damier Philippe; Destée Alain; Martinez Maria; Penet Christiane; Rasco Olivier; Tison François; Tranchan Christine; Vérin Marc
LRRK2 exon 41 mutations in sporadic Parkinson disease in Europeans.
Archives of neurology 2007;64(3):425-30.
2007: Agid Yves; Buzsáki György; Diamond David M; Frackowiak Richard; Giedd Jay; Girault Jean-Antoine; Grace Anthony; Lambert Jeremy J; Manji Husseini; Mayberg Helen; Popoli Maurizio; Prochiantz Alain; Richter-Levin Gal; Somogyi Peter; Spedding Michael; Svenningsson Per; Weinberger Daniel
How can drug discovery for psychiatric disorders be improved?
Nature reviews. Drug discovery 2007;6(3):189-201.
2007: Vidailhet Marie; Vercueil Laurent; Houeto Jean-Luc; Krystkowiak Pierre; Lagrange Christelle; Yelnik Jerôme; Bardinet Eric; Benabid Alim-Louis; Navarro Soledad; Dormont Didier; Grand Sylvie; Blond Serge; Ardouin Claire; Pillon Bernard; Dujardin Katy; Hahn-Barma Valérie; Agid Yves; Destée Alain; Pollak Pierre;
Bilateral, pallidal, deep-brain stimulation in primary generalised dystonia: a prospective 3 year follow-up study.
Lancet neurology 2007;6(3):223-9.
2007: De Cock Valérie Cochen; Vidailhet Marie; Leu Smaranda; Texeira Antonio; Apartis Emmanuelle; Elbaz Alexis; Roze Emmanuel; Willer Jean Claude; Derenne Jean Philippe; Agid Yves; Arnulf Isabelle
Restoration of normal motor control in Parkinson's disease during REM sleep.
Brain : a journal of neurology 2007;130(Pt 2):450-6.
2007: Schüpbach W M M; Maltête D; Houeto J L; du Montcel S Tezenas; Mallet L; Welter M L; Gargiulo M; Béhar C; Bonnet A M; Czernecki V; Pidoux B; Navarro S; Dormont D; Cornu P; Agid Y
Neurosurgery at an earlier stage of Parkinson disease: a randomized, controlled trial.
Neurology 2007;68(4):267-71.
2007: Schüpbach Michael W M; Welter Marie Laure; Bonnet Anne Marie; Elbaz Alexis; Grossardt Brandon R; Mesnage Valerie; Houeto Jean Luc; Maltête David; Mallet Luc; Rocca Walter A; Mallet Alain; Agid Yves
Mortality in patients with Parkinson's disease treated by stimulation of the subthalamic nucleus.
Movement disorders : official journal of the Movement Disorder Society 2007;22(2):257-61.
2007: Yelnik Jérôme; Bardinet Eric; Dormont Didier; Malandain Grégoire; Ourselin Sébastien; Tandé Dominique; Karachi Carine; Ayache Nicholas; Cornu Philippe; Agid Yves
A three-dimensional, histological and deformable atlas of the human basal ganglia. I. Atlas construction based on immunohistochemical and MRI data.
NeuroImage 2007;34(2):618-38.
2007: Schüpbach Michael; Lohmann Ebba; Anheim Mathieu; Lesage Suzanne; Czernecki Virginie; Yaici Sadek; Worbe Yulia; Charles Perrine; Welter Marie-Laure; Pollak Pierre; Dürr Alexandra; Agid Yves; Brice Alexis
Subthalamic nucleus stimulation is efficacious in patients with Parkinsonism and LRRK2 mutations.
Movement disorders : official journal of the Movement Disorder Society 2007;22(1):119-22.
2006: Sedel F; Ribeiro M J; Remy P; Blau N; Saudubray J-M; Agid Y
Dihydropteridine reductase deficiency: levodopa's long-term effectiveness without dyskinesia.
Neurology 2006;67(12):2243-5.
2006: Ardouin Claire; Voon Valerie; Worbe Yulia; Abouazar Nehman; Czernecki Virginie; Hosseini Hassan; Pelissolo Antoine; Moro Elena; Lhommée Eugénie; Lang Anthony E; Agid Yves; Benabid Alim-Louis; Pollak Pierre; Mallet Luc; Krack Paul
Pathological gambling in Parkinson's disease improves on chronic subthalamic nucleus stimulation.
Movement disorders : official journal of the Movement Disorder Society 2006;21(11):1941-6.
2006: Bloch F; Houeto J L; Tezenas du Montcel S; Bonneville F; Etchepare F; Welter M L; Rivaud-Pechoux S; Hahn-Barma V; Maisonobe T; Behar C; Lazennec J Y; Kurys E; Arnulf I; Bonnet A M; Agid Y
Parkinson's disease with camptocormia.
Journal of neurology, neurosurgery, and psychiatry 2006;77(11):1223-8.
2006: Houeto Jean-Luc; Mallet Luc; Mesnage Valérie; Tezenas du Montcel Sophie; Béhar Cécile; Gargiulo Marcela; Torny Frederic; Pelissolo Antoine; Welter Marie-Laure; Agid Yves
Subthalamic stimulation in Parkinson disease: behavior and social adaptation.
Archives of neurology 2006;63(8):1090-5.
2006: Schüpbach M; Gargiulo M; Welter M L; Mallet L; Béhar C; Houeto J L; Maltête D; Mesnage V; Agid Y
Neurosurgery in Parkinson disease: a distressed mind in a repaired body?
Neurology 2006;66(12):1811-6.
2006: Contarino Maria Fiorella; Welter Marie Laure; Agid Yves; Hartmann Andreas
Orthostatic tremor in monozygotic twins.
Neurology 2006;66(10):1600-1.
2006: Pillon B; Ardouin C; Dujardin K; Vittini P; Pelissolo A; Cottencin O; Vercueil L; Houeto J-L; Krystkowiak P; Agid Y; Destée A; Pollak P; Vidailhet M;
Preservation of cognitive function in dystonia treated by pallidal stimulation.
Neurology 2006;66(10):1556-8.
2006: Etchepare Fabien; Rozenberg Sylvie; Mirault Tristan; Bonnet Anne-Marie; Lecorre Colette; Agid Yves; Bourgeois Pierre; Fautrel Bruno
Back problems in Parkinson's disease: an underestimated problem.
Joint, bone, spine : revue du rhumatisme 2006;73(3):298-302.
2006: Ibáñez Pablo; Lesage Suzanne; Lohmann Ebba; Thobois Stéphane; De Michele Giuseppe; Borg Michel; Agid Yves; Dürr Alexandra; Brice Alexis;
Mutational analysis of the PINK1 gene in early-onset parkinsonism in Europe and North Africa.
Brain : a journal of neurology 2006;129(Pt 3):686-94.
2006: Sedel Frédéric; Friderici Karen; Nummy Katherine; Caillaud Catherine; Chabli Allel; Dürr Alexandra; Lubetzki Catherine; Agid Yves
Atypical Gilles de la Tourette Syndrome with beta-mannosidase deficiency.
Archives of neurology 2006;63(1):129-31.
2006: Agid Y; Schüpbach M; Gargiulo M; Mallet L; Houeto J L; Behar C; Maltête D; Mesnage V; Welter M L
Neurosurgery in Parkinson's disease: the doctor is happy, the patient less so?
Journal of neural transmission. Supplementum 2006;(70):409-14.
2005: Pessiglione Mathias; Czernecki Virginie; Pillon Bernard; Dubois Bruno; Schüpbach Michael; Agid Yves; Tremblay Léon
An effect of dopamine depletion on decision-making: the temporal coupling of deliberation and execution.
Journal of cognitive neuroscience 2005;17(12):1886-96.
2005: Schüpbach W M M; Chastan N; Welter M L; Houeto J L; Mesnage V; Bonnet A M; Czernecki V; Maltête D; Hartmann A; Mallet L; Pidoux B; Dormont D; Navarro S; Cornu P; Mallet A; Agid Y
Stimulation of the subthalamic nucleus in Parkinson's disease: a 5 year follow up.
Journal of neurology, neurosurgery, and psychiatry 2005;76(12):1640-4.
2005: Lesage Suzanne; Ibanez Pablo; Lohmann Ebba; Pollak Pierre; Tison François; Tazir Myriem; Leutenegger Anne-Louise; Guimaraes Joao; Bonnet Anne-Marie; Agid Yves; Dürr Alexandra; Brice Alexis;
G2019S LRRK2 mutation in French and North African families with Parkinson's disease.
Annals of neurology 2005;58(5):784-7.
2005: Klebe Stephan; Durr Alexandra; Rentschler Alexander; Hahn-Barma Valerie; Abele Michael; Bouslam Naima; Schöls Ludger; Jedynak Pierre; Forlani Sylvie; Denis Elodie; Dussert Christel; Agid Yves; Bauer Peter; Globas Christoph; Wüllner Ullrich; Brice Alexis; Riess Olaf; Stevanin Giovanni
New mutations in protein kinase Cgamma associated with spinocerebellar ataxia type 14.
Annals of neurology 2005;58(5):720-9.
2005: Rodriguez-Oroz M C; Obeso J A; Lang A E; Houeto J-L; Pollak P; Rehncrona S; Kulisevsky J; Albanese A; Volkmann J; Hariz M I; Quinn N P; Speelman J D; Guridi J; Zamarbide I; Gironell A; Molet J; Pascual-Sedano B; Pidoux B; Bonnet A M; Agid Y; Xie J; Benabid A-L; Lozano A M; Saint-Cyr J; Romito L; Contarino M F; Scerrati M; Fraix V; Van Blercom N
Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up.
Brain : a journal of neurology 2005;128(Pt 10):2240-9.
2005: Houeto J L; Karachi C; Mallet L; Pillon B; Yelnik J; Mesnage V; Welter M L; Navarro S; Pelissolo A; Damier P; Pidoux B; Dormont D; Cornu P; Agid Y
Tourette's syndrome and deep brain stimulation.
Journal of neurology, neurosurgery, and psychiatry 2005;76(7):992-5.
2005: Czernecki V; Pillon B; Houeto J L; Welter M L; Mesnage V; Agid Y; Dubois B
Does bilateral stimulation of the subthalamic nucleus aggravate apathy in Parkinson's disease?
Journal of neurology, neurosurgery, and psychiatry 2005;76(6):775-9.
2005: Bonneville F; Welter M L; Elie C; du Montcel S Tezenas; Hasboun D; Menuel C; Houeto J L; Bonnet A M; Mesnage V; Pidoux B; Navarro S; Cornu P; Agid Y; Dormont D
Parkinson disease, brain volumes, and subthalamic nucleus stimulation.
Neurology 2005;64(9):1598-604.
2005: Caer Morgane; Viala Karine; Levy Richard; Maisonobe Thierry; Chochon Florence; Lombès Agnès; Agid Yves
Adult-onset chorea and mitochondrial cytopathy.
Movement disorders : official journal of the Movement Disorder Society 2005;20(4):490-2.
2005: Arnulf Isabelle; Merino-Andreu Milagros; Bloch Frédéric; Konofal Eric; Vidailhet Marie; Cochen Valérie; Derenne Jean-Philippe; Agid Yves
REM sleep behavior disorder and REM sleep without atonia in patients with progressive supranuclear palsy.
Sleep 2005;28(3):349-54.
2005: Vidailhet Marie; Vercueil Laurent; Houeto Jean-Luc; Krystkowiak Pierre; Benabid Alim-Louis; Cornu Philippe; Lagrange Christelle; Tézenas du Montcel Sophie; Dormont Didier; Grand Sylvie; Blond Serge; Detante Olivier; Pillon Bernard; Ardouin Claire; Agid Yves; Destée Alain; Pollak Pierre;
Bilateral deep-brain stimulation of the globus pallidus in primary generalized dystonia.
The New England journal of medicine 2005;352(5):459-67.
2005: Bardinet Eric; Dormont Didier; Malandain Grégoire; Bhattacharjee Manik; Pidoux Bernard; Saleh Christian; Cornu Philippe; Ayache Nicholas; Agid Yves; Yelnik Jérôme
Retrospective cross-evaluation of an histological and deformable 3D atlas of the basal ganglia on series of Parkinsonian patients treated by deep brain stimulation.
Medical image computing and computer-assisted intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention 2005;8(Pt 2):385-93.
2005: Brooks D J; Agid Y; Eggert K; Widner H; Ostergaard K; Holopainen A;
Treatment of end-of-dose wearing-off in parkinson's disease: stalevo (levodopa/carbidopa/entacapone) and levodopa/DDCI given in combination with Comtess/Comtan (entacapone) provide equivalent improvements in symptom control superior to that of traditional levodopa/DDCI treatment.
European neurology 2005;53(4):197-202.
2004: Kreisler Alexandre; Stankoff Bruno; Ribeiro Maria João; Agid Yves; Lubetzki Catherine; Fontaine Bertrand
Unexpected aggravation of Parkinson's disease by a mesencephalic multiple sclerosis lesion.
Journal of neurology 2004;251(12):1526-7.
2004: Dormont Didier; Ricciardi Kenneth G; Tandé Dominique; Parain Karine; Menuel Carole; Galanaud Damien; Navarro Soledad; Cornu Philippe; Agid Yves; Yelnik Jérôme
Is the subthalamic nucleus hypointense on T2-weighted images? A correlation study using MR imaging and stereotactic atlas data.
AJNR. American journal of neuroradiology 2004;25(9):1516-23.
2004: Turny F; Jedynak P; Agid Y
[Athetosis or dystonia?]
Revue neurologique 2004;160(8-9):759-64.
2004: Ibáñez P; Bonnet A-M; Débarges B; Lohmann E; Tison F; Pollak P; Agid Y; Dürr A; Brice A
Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease.
Lancet 2004;364(9440):1169-71.
2004: Olanow C Warren; Agid Yves; Mizuno Yoshi; Albanese Alberto; Bonuccelli Ubaldo; Damier Philip; De Yebenes Justo; Gershanik Oscar; Guttman Mark; Grandas F; Hallett Mark; Hornykiewicz Ole; Jenner Peter; Katzenschlager R; Langston William J; LeWitt Peter; Melamed Eldad; Mena M A; Michel P P; Mytilineou Catherine; Obeso Jose A; Poewe Werner; Quinn Niall; Raisman-Vozari R; Rajput Ali H; Rascol Olivier; Sampaio Christina; Stocchi Fabrizio
Levodopa in the treatment of Parkinson's disease: current controversies.
Movement disorders : official journal of the Movement Disorder Society 2004;19(9):997-1005.
2004: Grabli David; McCairn Kevin; Hirsch Etienne C; Agid Yves; Féger Jean; François Chantal; Tremblay Léon
Behavioural disorders induced by external globus pallidus dysfunction in primates: I. Behavioural study.
Brain : a journal of neurology 2004;127(Pt 9):2039-54.
2004: Payoux Pierre; Remy Philippe; Damier Philipe; Miloudi Malika; Loubinoux Isabelle; Pidoux Bernard; Gaura Véronique; Rascol Olivier; Samson Yves; Agid Yves
Subthalamic nucleus stimulation reduces abnormal motor cortical overactivity in Parkinson disease.
Archives of neurology 2004;61(8):1307-13.
2004: Jedynak Pierre; Agid Yves
Primary orthostatic tremor and unsteadiness.
Movement disorders : official journal of the Movement Disorder Society 2004;19(8):989.
2004: Ibáñez P; Lohmann E; Pollak P; Durif F; Tranchant C; Agid Y; Dürr A; Brice A;
Absence of NR4A2 exon 1 mutations in 108 families with autosomal dominant Parkinson disease.
Neurology 2004;62(11):2133-4.
2004: Mesnage V; Houeto J L; Bonnet A M; Clavier I; Arnulf I; Cattelin F; Le Fur G; Damier P; Welter M L; Agid Y
Neurokinin B, neurotensin, and cannabinoid receptor antagonists and Parkinson disease.
Clinical neuropharmacology 2004;27(3):108-10.
2004: Le Ber Isabelle; Bouslam Naïma; Rivaud-Péchoux Sophie; Guimarães João; Benomar Ali; Chamayou Céline; Goizet Cyril; Moreira Maria-Ceù; Klur Sandra; Yahyaoui Mohamed; Agid Yves; Koenig Michel; Stevanin Giovanni; Brice Alexis; Dürr Alexandra
Frequency and phenotypic spectrum of ataxia with oculomotor apraxia 2: a clinical and genetic study in 18 patients.
Brain : a journal of neurology 2004;127(Pt 4):759-67.
2004: Maltête David; Navarro Soledad; Welter Marie-Laure; Roche Sabine; Bonnet Anne-Marie; Houeto Jean-Luc; Mesnage Valérie; Pidoux Bernard; Dormont Didier; Cornu Philippe; Agid Yves
Subthalamic stimulation in Parkinson disease: with or without anesthesia?
Archives of neurology 2004;61(3):390-2.
2004: Welter Marie-Laure; Houeto Jean-Luc; Bonnet Anne-Marie; Bejjani Paul-Boulos; Mesnage Valérie; Dormont Didier; Navarro Soledad; Cornu Philippe; Agid Yves; Pidoux Bernard
Effects of high-frequency stimulation on subthalamic neuronal activity in parkinsonian patients.
Archives of neurology 2004;61(1):89-96.
2003: Jarraya Bechir; Bonnet Anne-Marie; Duyckaerts Charles; Houeto Jean-Luc; Cornu Philippe; Hauw Jean-Jacques; Agid Yves
Parkinson's disease, subthalamic stimulation, and selection of candidates: a pathological study.
Movement disorders : official journal of the Movement Disorder Society 2003;18(12):1517-20.
2003: Ibáñez P; De Michele G; Bonifati V; Lohmann E; Thobois S; Pollak P; Agid Y; Heutink P; Dürr A; Brice A;
Screening for DJ-1 mutations in early onset autosomal recessive parkinsonism.
Neurology 2003;61(10):1429-31.
2003: Lücking Christoph-Burkhard; Chesneau Véronique; Lohmann Ebba; Verpillat Patrice; Dulac Cyprien; Bonnet Anne-Marie; Gasparini Francesca; Agid Yves; Dürr Alexandra; Brice Alexis
Coding polymorphisms in the parkin gene and susceptibility to Parkinson disease.
Archives of neurology 2003;60(9):1253-6.
2003: Faucheux Baptiste A; Martin Marie-Elise; Beaumont Carole; Hauw Jean-Jacques; Agid Yves; Hirsch Etienne C
Neuromelanin associated redox-active iron is increased in the substantia nigra of patients with Parkinson's disease.
Journal of neurochemistry 2003;86(5):1142-8.
2003: Lohmann Ebba; Periquet Magali; Bonifati Vincenzo; Wood Nick W; De Michele Giuseppe; Bonnet Anne-Marie; Fraix Valérie; Broussolle Emmanuel; Horstink Martin W I M; Vidailhet Marie; Verpillat Patrice; Gasser Thomas; Nicholl David; Teive Hélio; Raskin Salmo; Rascol Olivier; Destée Alain; Ruberg Merle; Gasparini Francesca; Meco Giuseppe; Agid Yves; Durr Alexandra; Brice Alexis;
How much phenotypic variation can be attributed to parkin genotype?
Annals of neurology 2003;54(2):176-85.
2003: Waubant Emmanuelle; Tezenas du Montcel Sophie; Jedynak Charles; Obadia Michael; Hosseini Hassan; Damier Philippe; Lubetzki Catherine; Agid Yves; Degos Jean-Denis
Multiple sclerosis tremor and the Stewart-Holmes manoeuvre.
Movement disorders : official journal of the Movement Disorder Society 2003;18(8):948-52.
2003: Brandel Jean-Philippe; Preece Michael; Brown Paul; Croes Esther; Laplanche Jean-Louis; Agid Yves; Will Robert; Alpérovitch Annick
Distribution of codon 129 genotype in human growth hormone-treated CJD patients in France and the UK.
Lancet 2003;362(9378):128-30.
2003: Yelnik Jérôme; Damier Philippe; Demeret Sophie; Gervais David; Bardinet Eric; Bejjani Boulos-Paul; François Chantal; Houeto Jean-Luc; Arnule Isabelle; Dormont Didier; Galanaud Damien; Pidoux Bernard; Cornu Philippe; Agid Yves
Localization of stimulating electrodes in patients with Parkinson disease by using a three-dimensional atlas-magnetic resonance imaging coregistration method.
Journal of neurosurgery 2003;99(1):89-99.
2003: Pessiglione Mathias; Guehl Dominique; Agid Yves; Hirsch Etienne C; Féger Jean; Tremblay Léon
Impairment of context-adapted movement selection in a primate model of presymptomatic Parkinson's disease.
Brain : a journal of neurology 2003;126(Pt 6):1392-408.
2003: Periquet Magali; Latouche Morwena; Lohmann Ebba; Rawal Nina; De Michele Giuseppe; Ricard Sylvain; Teive Hélio; Fraix Valérie; Vidailhet Marie; Nicholl David; Barone Paolo; Wood Nick W; Raskin Salmo; Deleuze Jean-François; Agid Yves; Dürr Alexandra; Brice Alexis;
Parkin mutations are frequent in patients with isolated early-onset parkinsonism.
Brain : a journal of neurology 2003;126(Pt 6):1271-8.
2003: Thobois Stéphane; Ribeiro Maria-Joao; Lohmann Ebba; Dürr Alexandra; Pollak Pierre; Rascol Olivier; Guillouet Stéphane; Chapoy Elizabeth; Costes Nicolas; Agid Yves; Remy Philippe; Brice Alexis; Broussolle Emmanuel;
Young-onset Parkinson disease with and without parkin gene mutations: a fluorodopa F 18 positron emission tomography study.
Archives of neurology 2003;60(5):713-8.
2003: Houeto Jean-Luc; Welter Marie-Laure; Bejjani Paul-Boulos; Tezenas du Montcel Sophie; Bonnet Anne-Marie; Mesnage Valerie; Navarro Soledad; Pidoux Bernard; Dormont Didier; Cornu Philippe; Agid Yves
Subthalamic stimulation in Parkinson disease: intraoperative predictive factors.
Archives of neurology 2003;60(5):690-4.
2003: Merino-Andreu M; Arnulf I; Konofal E; Derenne J P; Agid Y
Unawareness of naps in Parkinson's disease and in disorders with excessive daytime sleepiness.
Neurology 2003;60(9):1553-4.
2003: Rawal N; Periquet M; Lohmann E; Lücking C B; Teive H A; Ambrosio G; Raskin S; Lincoln S; Hattori N; Guimaraes J; Horstink M W I M; Dos Santos Bele W; Brousolle E; Destée A; Mizuno Y; Farrer M; Deleuze J-F; De Michele G; Agid Y; Dürr A; Brice A;
New parkin mutations and atypical phenotypes in families with autosomal recessive parkinsonism.
Neurology 2003;60(8):1378-81.
2003: Agid Y;
[Address from the president of French Society of Neurologists for 2002]
Revue neurologique 2003;159(3):332-3.
2003: Gerardin Emmanuel; Lehéricy Stéphane; Pochon Jean-Baptiste; Tézenas du Montcel Sophie; Mangin Jean-François; Poupon Fabrice; Agid Yves; Le Bihan Denis; Marsault Claude
Foot, hand, face and eye representation in the human striatum.
Cerebral cortex (New York, N.Y. : 1991) 2003;13(2):162-9.
2003: Houeto J L; Mesnage V; Welter M L; Mallet L; Agid Y; Bejjani B P
Subthalamic DBS replaces levodopa in Parkinson's disease: two-year follow-up.
Neurology 2003;60(1):154-5; author reply 154-5.
2003: Olanow C Warren; Schapira Anthony H V; Agid Yves
Neuroprotection for Parkinson's disease: prospects and promises.
Annals of neurology 2003;53 Suppl 3():S1-2.
2003: Agid Y; Arnulf I; Bejjani P; Bloch F; Bonnet A M; Damier P; Dubois B; François C; Houeto J L; Iacono D; Karachi C; Mesnage V; Messouak O; Vidailhet M; Welter M L; Yelnik J
Parkinson's disease is a neuropsychiatric disorder.
Advances in neurology 2003;91():365-70.
2002: Michel P P; Hirsch E C; Agid Y
[Parkinson disease: mechanisms of cell death]
Revue neurologique 2002;158 Spec no 1():S24-32.
2002: Mesnage V; Houeto J-L; Welter M-L; Agid Y; Pidoux B; Dormont D; Cornu P
Parkinson's disease: neurosurgery at an earlier stage?
Journal of neurology, neurosurgery, and psychiatry 2002;73(6):778-9.
2002: Bejjani B P; Houeto J L; Hariz M; Yelnik J; Mesnage V; Bonnet A M; Pidoux B; Dormont D; Cornu P; Agid Y
Aggressive behavior induced by intraoperative stimulation in the triangle of Sano.
Neurology 2002;59(9):1425-7.
2002: Faucheux Baptiste A; Martin Marie-Elise; Beaumont Carole; Hunot Stéphane; Hauw Jean-Jacques; Agid Yves; Hirsch Etienne C
Lack of up-regulation of ferritin is associated with sustained iron regulatory protein-1 binding activity in the substantia nigra of patients with Parkinson's disease.
Journal of neurochemistry 2002;83(2):320-30.
2002: Mallet Luc; Mesnage Valérie; Houeto Jean-Luc; Pelissolo Antoine; Yelnik Jérôme; Behar Cécile; Gargiulo Marcella; Welter Marie-Laure; Bonnet Anne-Marie; Pillon Bernard; Cornu Philippe; Dormont Didier; Pidoux Bernard; Allilaire Jean-François; Agid Yves
Compulsions, Parkinson's disease, and stimulation.
Lancet 2002;360(9342):1302-4.
2002: Vyas Sheela; Biguet Nicole Faucon; Michel Patrick P; Monaco Lucia; Foulkes Nicholas S; Evan Gerard I; Sassone-Corsi Paolo; Agid Yves
Molecular mechanisms of neuronal cell death: implications for nuclear factors responding to cAMP and phorbol esters.
Molecular and cellular neurosciences 2002;21(1):1-14.
2002: Rawal Nina; Periquet Magali; Dürr Alexandra; de Michele Giuseppe; Bonifati Vincenzo; Teive Helio A; Raskin Salmo; Guimaraes Joao; Agid Yves; Brice Alexis;
Exclusion of the Nurr1 gene in autosomal recessive Parkinson's disease.
Journal of neurology 2002;249(8):1127-9.
2002: Agid Y; Olanow C W; Mizuno Y
Levodopa: why the controversy?
Lancet 2002;360(9332):575.
2002: Borie Claire; Gasparini Francesca; Verpillat Patrice; Bonnet Anne-Marie; Agid Yves; Hetet Gilles; Brice Alexis; Dürr Alexandra; Grandchamp Bernard;
Association study between iron-related genes polymorphisms and Parkinson's disease.
Journal of neurology 2002;249(7):801-4.
2002: Douhou Aïcha; Debeir Thomas; Murer Mario Gustavo; Do Louis; Dufour Noëlle; Blanchard Véronique; Moussaoui Saliha; Bohme Georg Andrees; Agid Yves; Raisman-Vozari Rita
Effect of chronic treatment with riluzole on the nigrostriatal dopaminergic system in weaver mutant mice.
Experimental neurology 2002;176(1):247-53.
2002: Houeto J L; Mesnage V; Mallet L; Pillon B; Gargiulo M; du Moncel S Tezenas; Bonnet A M; Pidoux B; Dormont D; Cornu P; Agid Y
Behavioural disorders, Parkinson's disease and subthalamic stimulation.
Journal of neurology, neurosurgery, and psychiatry 2002;72(6):701-7.
2002: Arnulf I; Konofal E; Merino-Andreu M; Houeto J L; Mesnage V; Welter M L; Lacomblez L; Golmard J L; Derenne J P; Agid Y
Parkinson's disease and sleepiness: an integral part of PD.
Neurology 2002;58(7):1019-24.
2002: Bejjani B-P; Arnulf I; Houeto J-L; Milea D; Demeret S; Pidoux B; Damier P; Cornu P; Dormont D; Agid Y
Concurrent excitatory and inhibitory effects of high frequency stimulation: an oculomotor study.
Journal of neurology, neurosurgery, and psychiatry 2002;72(4):517-22.
2002: Labauge P; Amer L O; Simonetta-Moreau M; Attané F; Tannier C; Clanet M; Castelnovo G; An-Gourfinkel I; Agid Y; Brice A; Ducros A; LeGuern E
Absence of linkage to 8q24 in a European family with familial adult myoclonic epilepsy (FAME).
Neurology 2002;58(6):941-4.
2002: Welter M L; Houeto J L; Tezenas du Montcel S; Mesnage V; Bonnet A M; Pillon B; Arnulf I; Pidoux B; Dormont D; Cornu P; Agid Y
Clinical predictive factors of subthalamic stimulation in Parkinson's disease.
Brain : a journal of neurology 2002;125(Pt 3):575-83.
2002: Gourfinkel-An Isabelle; Vila Miquel; Faucheux Baptiste; Duyckaerts Charles; Viallet François; Hauw Jean-Jacques; Brice Alexis; Agid Yves; Hirsch Etienne C
Metabolic changes in the basal ganglia of patients with Huntington's disease: an in situ hybridization study of cytochrome oxidase subunit I mRNA.
Journal of neurochemistry 2002;80(3):466-76.
2002: Hartmann A; Mouatt-Prigent A; Faucheux B A; Agid Y; Hirsch E C
FADD: A link between TNF family receptors and caspases in Parkinson's disease.
Neurology 2002;58(2):308-10.
2001: Waubant E; Alizé P; Tourbah A; Agid Y
Paroxysmal dystonia (tonic spasm) in multiple sclerosis.
Neurology 2001;57(12):2320-1.
2001: Agid Y
Levodopa. Is toxicity a myth? 1998.
Neurology 2001;57(10 Suppl 3):S46-51.
2001: Marin C; Jiménez A; Bonastre M; Vila M; Agid Y; Hirsch E C; Tolosa E
LY293558, an AMPA glutamate receptor antagonist, prevents and reverses levodopa-induced motor alterations in Parkinsonian rats.
Synapse (New York, N.Y.) 2001;42(1):40-7.
2001: Lehéricy S; Grand S; Pollak P; Poupon F; Le Bas J F; Limousin P; Jedynak P; Marsault C; Agid Y; Vidailhet M
Clinical characteristics and topography of lesions in movement disorders due to thalamic lesions.
Neurology 2001;57(6):1055-66.
2001: Rascol O; Arnulf I; Peyro-Saint Paul H; Brefel-Courbon C; Vidailhet M; Thalamas C; Bonnet A M; Descombes S; Bejjani B; Fabre N; Montastruc J L; Agid Y
Idazoxan, an alpha-2 antagonist, and L-DOPA-induced dyskinesias in patients with Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2001;16(4):708-13.
2001: Verpillat P; Bouley S; Campion D; Hannequin D; Dubois B; Belliard S; Puel M; Thomas-Antérion C; Agid Y; Brice A; Clerget-Darpoux F
Use of haplotype information to test involvement of the LRP gene in Alzheimer's disease in the French population.
European journal of human genetics : EJHG 2001;9(6):464-8.
2001: Arnulf I; Vidailhet M; Bonnet A M; Descombes S; Jaillon C; Agid Y; Brefel C; Rascol O; Xie J; Pollak P; Cattelin F
Blockade of cholecystokinin-A receptors has no effect on dyskinesias in Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 2001;70(6):812-3.
2001: Muriel M P; Agid Y; Hirsch E
Plasticity of afferent fibers to striatal neurons bearing D1 dopamine receptors in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2001;16(3):435-41.
2001: Descombes S; Bonnet A M; Gasser U E; Thalamas C; Dingemanse J; Arnulf I; Bareille M P; Agid Y; Rascol O
Dual-release formulation, a novel principle in L-dopa treatment of Parkinson's disease.
Neurology 2001;56(9):1239-42.
2001: Vidailhet M; Tassin J; Durif F; Nivelon-Chevallier A; Agid Y; Brice A; Dürr A
A major locus for several phenotypes of myoclonus--dystonia on chromosome 7q.
Neurology 2001;56(9):1213-6.
2001: Bensaid M; Faucheux B A; Hirsch E; Agid Y; Soubrié P; Oury-Donat F
Expression of tachykinin NK2 receptor mRNA in human brain.
Neuroscience letters 2001;303(1):25-8.
2001: Hartmann A; Troadec J D; Hunot S; Kikly K; Faucheux B A; Mouatt-Prigent A; Ruberg M; Agid Y; Hirsch E C
Caspase-8 is an effector in apoptotic death of dopaminergic neurons in Parkinson's disease, but pathway inhibition results in neuronal necrosis.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2001;21(7):2247-55.
2001: Zarate-Lagunes M; Gu W J; Blanchard V; Francois C; Muriel M P; Mouatt-Prigent A; Bonici B; Parent A; Hartmann A; Yelnik J; Boehme G A; Pradier L; Moussaoui S; Faucheux B; Raisman-Vozari R; Agid Y; Brice A; Hirsch E C
Parkin immunoreactivity in the brain of human and non-human primates: an immunohistochemical analysis in normal conditions and in Parkinsonian syndromes.
The Journal of comparative neurology 2001;432(2):184-96.
2001: Turmel H; Hartmann A; Parain K; Douhou A; Srinivasan A; Agid Y; Hirsch E C
Caspase-3 activation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice.
Movement disorders : official journal of the Movement Disorder Society 2001;16(2):185-9.
2001: Hartmann A; Michel P P; Troadec J D; Mouatt-Prigent A; Faucheux B A; Ruberg M; Agid Y; Hirsch E C
Is Bax a mitochondrial mediator in apoptotic death of dopaminergic neurons in Parkinson's disease?
Journal of neurochemistry 2001;76(6):1785-93.
2001: Periquet M; Lücking C; Vaughan J; Bonifati V; Dürr A; De Michele G; Horstink M; Farrer M; Illarioshkin S N; Pollak P; Borg M; Brefel-Courbon C; Denefle P; Meco G; Gasser T; Breteler M M; Wood N; Agid Y; Brice A;
Origin of the mutations in the parkin gene in Europe: exon rearrangements are independent recurrent events, whereas point mutations may result from Founder effects.
American journal of human genetics 2001;68(3):617-26.
2001: Bonifati V; De Michele G; Lücking C B; Dürr A; Fabrizio E; Ambrosio G; Vanacore N; De Mari M; Marconi R; Capus L; Breteler M M; Gasser T; Oostra B; Wood N; Agid Y; Filla A; Meco G; Brice A;
The parkin gene and its phenotype. Italian PD Genetics Study Group, French PD Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2001;22(1):51-2.
2001: Brandel J P; Peoc'h K; Beaudry P; Welaratne A; Bottos C; Agid Y; Laplanche J L
14-3-3 protein cerebrospinal fluid detection in human growth hormone-treated Creutzfeldt-Jakob disease patients.
Annals of neurology 2001;49(2):257-60.
2001: Lambeng N; Michel P P; Agid Y; Ruberg M
The relationship between differentiation and survival in PC12 cells treated with cyclic adenosine monophosphate in the presence of epidermal growth factor or nerve growth factor.
Neuroscience letters 2001;297(2):133-6.
2001: Damier P; Houeto J L; Bejjani B P; Arnulf I; Bonnet A M; Miloudy M; Agid Y
The role of the pallidum in Parkinson's disease gait. Lessons from pallidal stimulation.
Advances in neurology 2001;87():283-8.
2000: Jan C; François C; Tandé D; Yelnik J; Tremblay L; Agid Y; Hirsch E
Dopaminergic innervation of the pallidum in the normal state, in MPTP-treated monkeys and in parkinsonian patients.
The European journal of neuroscience 2000;12(12):4525-35.
2000: Arnulf I; Bejjani B P; Garma L; Bonnet A M; Houeto J L; Damier P; Derenne J P; Agid Y
Improvement of sleep architecture in PD with subthalamic nucleus stimulation.
Neurology 2000;55(11):1732-4.
2000: Cancel G; Duyckaerts C; Holmberg M; Zander C; Yvert G; Lebre A S; Ruberg M; Faucheux B; Agid Y; Hirsch E; Brice A
Distribution of ataxin-7 in normal human brain and retina.
Brain : a journal of neurology 2000;123 Pt 12():2519-30.
2000: Gerardin E; Sirigu A; Lehéricy S; Poline J B; Gaymard B; Marsault C; Agid Y; Le Bihan D
Partially overlapping neural networks for real and imagined hand movements.
Cerebral cortex (New York, N.Y. : 1991) 2000;10(11):1093-104.
2000: Hirsch E C; Périer C; Orieux G; François C; Féger J; Yelnik J; Vila M; Levy R; Tolosa E S; Marin C; Trinidad Herrero M; Obeso J A; Agid Y
Metabolic effects of nigrostriatal denervation in basal ganglia.
Trends in neurosciences 2000;23(10 Suppl):S78-85.
2000: Dubus P; Faucheux B; Boissière F; Groppi A; Vital C; Vital A; Agid Y; Hirsch E C; Merlio J P
Expression of Trk isoforms in brain regions and in the striatum of patients with Alzheimer's disease.
Experimental neurology 2000;165(2):285-94.
2000: Muriel M P; Lambeng N; Darios F; Michel P P; Hirsch E C; Agid Y; Ruberg M
Mitochondrial free calcium levels (Rhod-2 fluorescence) and ultrastructural alterations in neuronally differentiated PC12 cells during ceramide-dependent cell death.
The Journal of comparative neurology 2000;426(2):297-315.
2000: Périer C; Agid Y; Hirsch E C; Féger J
Ipsilateral and contralateral subthalamic activity after unilateral dopaminergic lesion.
Neuroreport 2000;11(14):3275-8.
2000: Bejjani B P; Arnulf I; Vidailhet M; Pidoux B; Damier P; Papadopoulos S; Bonnet A M; Cornu P; Dormont D; Agid Y
Irregular jerky tremor, myoclonus, and thalamus: a study using low-frequency stimulation.
Movement disorders : official journal of the Movement Disorder Society 2000;15(5):919-24.
2000: Houeto J L; Bejjani P B; Damier P; Staedler C; Bonnet A M; Pidoux B; Dormont D; Cornu P; Agid Y
Failure of long-term pallidal stimulation corrected by subthalamic stimulation in PD.
Neurology 2000;55(5):728-30.
2000: Verpillat P; Bouley S; Hannequin D; Belliard S; Puel M; Thomas-Anterion C; Dubois B; Agid Y; Campion D; Clerget-Darpoux F; Brice A
Alpha2-macroglobulin gene and Alzheimer's disease: confirmation of association by haplotypes analyses.
Annals of neurology 2000;48(3):400-2.
2000: Pillon B; Ardouin C; Damier P; Krack P; Houeto J L; Klinger H; Bonnet A M; Pollak P; Benabid A L; Agid Y
Neuropsychological changes between "off" and "on" STN or GPi stimulation in Parkinson's disease.
Neurology 2000;55(3):411-8.
2000: Arnulf I; Bonnet A M; Damier P; Bejjani B P; Seilhean D; Derenne J P; Agid Y
Hallucinations, REM sleep, and Parkinson's disease: a medical hypothesis.
Neurology 2000;55(2):281-8.
2000: Dürr A; Tassin J; Vidailhet M; Durif F; Jedynak P; Agid Y; Brice A
D2 dopamine receptor gene in myoclonic dystonia and essential myoclonus.
Annals of neurology 2000;48(1):127-8.
2000: Ransmayr G; Faucheux B; Nowakowski C; Kubis N; Federspiel S; Kaufmann W; Henin D; Hauw J J; Agid Y; Hirsch E C
Age-related changes of neuronal counts in the human pedunculopontine nucleus.
Neuroscience letters 2000;288(3):195-8.
2000: Tassin J; Dürr A; Bonnet A M; Gil R; Vidailhet M; Lücking C B; Goas J Y; Durif F; Abada M; Echenne B; Motte J; Lagueny A; Lacomblez L; Jedynak P; Bartholomé B; Agid Y; Brice A
Levodopa-responsive dystonia. GTP cyclohydrolase I or parkin mutations?
Brain : a journal of neurology 2000;123 ( Pt 6)():1112-21.
2000: Lücking C B; Dürr A; Bonifati V; Vaughan J; De Michele G; Gasser T; Harhangi B S; Meco G; Denèfle P; Wood N W; Agid Y; Brice A;
Association between early-onset Parkinson's disease and mutations in the parkin gene.
The New England journal of medicine 2000;342(21):1560-7.
2000: Bejjani B P; Arnulf I; Demeret S; Damier P; Bonnet A M; Houeto J L; Agid Y
Levodopa-induced dyskinesias in Parkinson's disease: is sensitization reversible?
Annals of neurology 2000;47(5):655-8.
2000: Bejjani B P; Gervais D; Arnulf I; Papadopoulos S; Demeret S; Bonnet A M; Cornu P; Damier P; Agid Y
Axial parkinsonian symptoms can be improved: the role of levodopa and bilateral subthalamic stimulation.
Journal of neurology, neurosurgery, and psychiatry 2000;68(5):595-600.
2000: Zalla T; Sirigu A; Pillon B; Dubois B; Agid Y; Grafman J
How patients with Parkinson's disease retrieve and manage cognitive event knowledge.
Cortex; a journal devoted to the study of the nervous system and behavior 2000;36(2):163-79.
2000: Houeto J L; Damier P; Bejjani P B; Staedler C; Bonnet A M; Arnulf I; Pidoux B; Dormont D; Cornu P; Agid Y
Subthalamic stimulation in Parkinson disease: a multidisciplinary approach.
Archives of neurology 2000;57(4):461-5.
2000: Bejjani B P; Dormont D; Pidoux B; Yelnik J; Damier P; Arnulf I; Bonnet A M; Marsault C; Agid Y; Philippon J; Cornu P
Bilateral subthalamic stimulation for Parkinson's disease by using three-dimensional stereotactic magnetic resonance imaging and electrophysiological guidance.
Journal of neurosurgery 2000;92(4):615-25.
2000: Gu W J; Abbas N; Lagunes M Z; Parent A; Pradier L; Bohme G A; Agid Y; Hirsch E C; Raisman-Vozari R; Brice A
Cloning of rat parkin cDNA and distribution of parkin in rat brain.
Journal of neurochemistry 2000;74(4):1773-6.
2000: Mouatt-Prigent A; Karlsson J O; Yelnik J; Agid Y; Hirsch E C
Calpastatin immunoreactivity in the monkey and human brain of control subjects and patients with Parkinson's disease.
The Journal of comparative neurology 2000;419(2):175-92.
2000: Arnulf I; Bejjani B P; Garma L; Bonnet A M; Damier P; Pidoux B; Dormont D; Cornu P; Derenne J P; Agid Y
Effect of low and high frequency thalamic stimulation on sleep in patients with Parkinson's disease and essential tremor.
Journal of sleep research 2000;9(1):55-62.
2000: Périer C; Vila M; Féger J; Agid Y; Hirsch E C
Functional activity of zona incerta neurons is altered after nigrostriatal denervation in hemiparkinsonian rats.
Experimental neurology 2000;162(1):215-24.
2000: Brassat D; Camuzat A; Vidailhet M; Feki I; Jedynak P; Klap P; Agid Y; Dürr A; Brice A
Frequency of the DYT1 mutation in primary torsion dystonia without family history.
Archives of neurology 2000;57(3):333-5.
2000: Stevanin G; Herman A; Dürr A; Jodice C; Frontali M; Agid Y; Brice A
Are (CTG)n expansions at the SCA8 locus rare polymorphisms?
Nature genetics 2000;24(3):213; author reply 215.
2000: Hartmann A; Hunot S; Michel P P; Muriel M P; Vyas S; Faucheux B A; Mouatt-Prigent A; Turmel H; Srinivasan A; Ruberg M; Evan G I; Agid Y; Hirsch E C
Caspase-3: A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(6):2875-80.
2000: Rivaud-Péchoux S; Vermersch A I; Gaymard B; Ploner C J; Bejjani B P; Damier P; Demeret S; Agid Y; Pierrot-Deseilligny C
Improvement of memory guided saccades in parkinsonian patients by high frequency subthalamic nucleus stimulation.
Journal of neurology, neurosurgery, and psychiatry 2000;68(3):381-4.
2000: Kubis N; Faucheux B A; Ransmayr G; Damier P; Duyckaerts C; Henin D; Forette B; Le Charpentier Y; Hauw J J; Agid Y; Hirsch E C
Preservation of midbrain catecholaminergic neurons in very old human subjects.
Brain : a journal of neurology 2000;123 ( Pt 2)():366-73.
2000: Agid Y
[How to examine a patient with Parkinson disease]
Revue neurologique 2000;156(1):17-22.
2000: Vila M; Périer C; Féger J; Yelnik J; Faucheux B; Ruberg M; Raisman-Vozari R; Agid Y; Hirsch E C
Evolution of changes in neuronal activity in the subthalamic nucleus of rats with unilateral lesion of the substantia nigra assessed by metabolic and electrophysiological measurements.
The European journal of neuroscience 2000;12(1):337-44.
2000: Agid Y
Will neurological practice be different during the 21st century.
Archives of neurology 2000;57(1):56-7.
2000: Yelnik J; Damier P; Bejjani B P; Francois C; Gervais D; Dormont D; Arnulf I; M Bonnet A; Cornu P; Pidoux B; Agid Y
Functional mapping of the human globus pallidus: contrasting effect of stimulation in the internal and external pallidum in Parkinson's disease.
Neuroscience 2000;101(1):77-87.
2000: Orieux G; Francois C; Féger J; Yelnik J; Vila M; Ruberg M; Agid Y; Hirsch E C
Metabolic activity of excitatory parafascicular and pedunculopontine inputs to the subthalamic nucleus in a rat model of Parkinson's disease.
Neuroscience 2000;97(1):79-88.
1999: Crozier S; Sirigu A; Lehéricy S; van de Moortele P F; Pillon B; Grafman J; Agid Y; Dubois B; LeBihan D
Distinct prefrontal activations in processing sequence at the sentence and script level: an fMRI study.
Neuropsychologia 1999;37(13):1469-76.
1999: Stevanin G; David G; Dürr A; Giunti P; Benomar A; Abada-Bendib M; Lee M S; Agid Y; Brice A
Multiple origins of the spinocerebellar ataxia 7 (SCA7) mutation revealed by linkage disequilibrium studies with closely flanking markers, including an intragenic polymorphism (G3145TG/A3145TG).
European journal of human genetics : EJHG 1999;7(8):889-96.
1999: Agid Y
Continuous high frequency stimulation of deep brain structures in brain pathology.
Brain research bulletin 1999;50(5-6):475.
1999: Agid Y; Ahlskog E; Albanese A; Calne D; Chase T; De Yebenes J; Factor S; Fahn S; Gershanik O; Goetz C; Koller W; Kurth M; Lang A; Lees A; Lewitt P; Marsden D; Melamed E; Michel P P; Mizuno Y; Obeso J; Oertel W; Olanow W; Poewe W; Pollak P; Tolosa E
Levodopa in the treatment of Parkinson's disease: a consensus meeting.
Movement disorders : official journal of the Movement Disorder Society 1999;14(6):911-3.
1999: François C; Yelnik J; Tandé D; Agid Y; Hirsch E C
Dopaminergic cell group A8 in the monkey: anatomical organization and projections to the striatum.
The Journal of comparative neurology 1999;414(3):334-47.
1999: Huillard d'Aignaux J; Costagliola D; Maccario J; Billette de Villemeur T; Brandel J P; Deslys J P; Hauw J J; Chaussain J L; Agid Y; Dormont D; Alpérovitch A
Incubation period of Creutzfeldt-Jakob disease in human growth hormone recipients in France.
Neurology 1999;53(6):1197-201.
1999: Brassat D; Durr A; Agid Y; Brice A
[Genetics of Parkinson disease]
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 1999;20(8):709-14.
1999: Agid Y
Parkinson's disease or Parkinson's diseases?
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 1999;53(7):301-2.
1999: Vidailhet M; Dupel C; Lehéricy S; Remy P; Dormont D; Serdaru M; Jedynak P; Veber H; Samson Y; Marsault C; Agid Y
Dopaminergic dysfunction in midbrain dystonia: anatomoclinical study using 3-dimensional magnetic resonance imaging and fluorodopa F 18 positron emission tomography.
Archives of neurology 1999;56(8):982-9.
1999: Ploner C J; Rivaud-Péchoux S; Gaymard B M; Agid Y; Pierrot-Deseilligny C
Errors of memory-guided saccades in humans with lesions of the frontal eye field and the dorsolateral prefrontal cortex.
Journal of neurophysiology 1999;82(2):1086-90.
1999: Ardouin C; Pillon B; Peiffer E; Bejjani P; Limousin P; Damier P; Arnulf I; Benabid A L; Agid Y; Pollak P
Bilateral subthalamic or pallidal stimulation for Parkinson's disease affects neither memory nor executive functions: a consecutive series of 62 patients.
Annals of neurology 1999;46(2):217-23.
1999: Damier P; Hirsch E C; Agid Y; Graybiel A M
The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease.
Brain : a journal of neurology 1999;122 ( Pt 8)():1437-48.
1999: Damier P; Hirsch E C; Agid Y; Graybiel A M
The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D(28K) immunohistochemistry.
Brain : a journal of neurology 1999;122 ( Pt 8)():1421-36.
1999: Bédard M A; Pillon B; Dubois B; Duchesne N; Masson H; Agid Y
Acute and long-term administration of anticholinergics in Parkinson's disease: specific effects on the subcortico-frontal syndrome.
Brain and cognition 1999;40(2):289-313.
1999: Agid Y; Lhermitte F
Facilitory paratonia and frontal lobe functioning.
Neurology 1999;53(1):241.
1999: Muriel M P; Bernard V; Levey A I; Laribi O; Abrous D N; Agid Y; Bloch B; Hirsch E C
Levodopa induces a cytoplasmic localization of D1 dopamine receptors in striatal neurons in Parkinson's disease.
Annals of neurology 1999;46(1):103-11.
1999: Vila M; Marin C; Ruberg M; Jimenez A; Raisman-Vozari R; Agid Y; Tolosa E; Hirsch E C
Systemic administration of NMDA and AMPA receptor antagonists reverses the neurochemical changes induced by nigrostriatal denervation in basal ganglia.
Journal of neurochemistry 1999;73(1):344-52.
1999: Bejjani B P; Damier P; Arnulf I; Thivard L; Bonnet A M; Dormont D; Cornu P; Pidoux B; Samson Y; Agid Y
Transient acute depression induced by high-frequency deep-brain stimulation.
The New England journal of medicine 1999;340(19):1476-80.
1999: Michel P P; Marien M; Ruberg M; Colpaert F; Agid Y
Adenosine prevents the death of mesencephalic dopaminergic neurons by a mechanism that involves astrocytes.
Journal of neurochemistry 1999;72(5):2074-82.
1999: Hunot S; Dugas N; Faucheux B; Hartmann A; Tardieu M; Debré P; Agid Y; Dugas B; Hirsch E C
FcepsilonRII/CD23 is expressed in Parkinson's disease and induces, in vitro, production of nitric oxide and tumor necrosis factor-alpha in glial cells.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1999;19(9):3440-7.
1999: Vermersch A I; Gaymard B M; Rivaud-Pechoux S; Ploner C J; Agid Y; Pierrot-Deseilligny C
Memory guided saccade deficit after caudate nucleus lesion.
Journal of neurology, neurosurgery, and psychiatry 1999;66(4):524-7.
1999: Abbas N; Lücking C B; Ricard S; Dürr A; Bonifati V; De Michele G; Bouley S; Vaughan J R; Gasser T; Marconi R; Broussolle E; Brefel-Courbon C; Harhangi B S; Oostra B A; Fabrizio E; Böhme G A; Pradier L; Wood N W; Filla A; Meco G; Denefle P; Agid Y; Brice A
A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease.
Human molecular genetics 1999;8(4):567-74.
1999: Faucheux B A; Bonnet A M; Agid Y; Hirsch E C
Blood vessels change in the mesencephalon of patients with Parkinson's disease.
Lancet 1999;353(9157):981-2.
1999: Murer M G; Raisman-Vozari R; Yan Q; Ruberg M; Agid Y; Michel P P
Survival factors promote BDNF protein expression in mesencephalic dopaminergic neurons.
Neuroreport 1999;10(4):801-5.
1999: Hirsch E; Hu L J; Prigent A; Constantin B; Agid Y; Drabkin H; Roche J
Distribution of semaphorin IV in adult human brain.
Brain research 1999;823(1-2):67-79.
1999: Hirsch E C; Hunot S; Faucheux B; Agid Y; Mizuno Y; Mochizuki H; Tatton W G; Tatton N; Olanow W C
Dopaminergic neurons degenerate by apoptosis in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1999;14(2):383-5.
1999: Durif F; Vidailhet M; Debilly B; Agid Y
Worsening of levodopa-induced dyskinesias by motor and mental tasks.
Movement disorders : official journal of the Movement Disorder Society 1999;14(2):242-5.
1999: Sabbagh N; Brice A; Marez D; Dürr A; Legrand M; Lo Guidice J M; Destée A; Agid Y; Broly F
CYP2D6 polymorphism and Parkinson's disease susceptibility.
Movement disorders : official journal of the Movement Disorder Society 1999;14(2):230-6.
1999: Rösler M; Anand R; Cicin-Sain A; Gauthier S; Agid Y; Dal-Bianco P; Stähelin H B; Hartman R; Gharabawi M
Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial.
BMJ (Clinical research ed.) 1999;318(7184):633-8.
1999: Lambeng N; Michel P P; Brugg B; Agid Y; Ruberg M
Mechanisms of apoptosis in PC12 cells irreversibly differentiated with nerve growth factor and cyclic AMP.
Brain research 1999;821(1):60-8.
1999: Parain K; Murer M G; Yan Q; Faucheux B; Agid Y; Hirsch E; Raisman-Vozari R
Reduced expression of brain-derived neurotrophic factor protein in Parkinson's disease substantia nigra.
Neuroreport 1999;10(3):557-61.
1999: Lebre A S; Durr A; Jedynak P; Ponsot G; Vidailhet M; Agid Y; Brice A
DYT1 mutation in French families with idiopathic torsion dystonia.
Brain : a journal of neurology 1999;122 ( Pt 1)():41-5.
1999: Ruzicka E; el Massioui F; Pillon B; Dubois B; Renault B; Agid Y
The effects of apomorphine on attentional processing in Parkinson's disease.
Sborník lékar?ský 1999;100(2):85-99.
1999: Damier P; Jaillon C; Clavier I; Arnulf I; Bonnet A M; Bejjani B P; Agid Y
Dyskinesias assessment in Phase II studies.
Movement disorders : official journal of the Movement Disorder Society 1999;14 Suppl 1():54-9.
1999: Vidailhet M; Bonnet A M; Marconi R; Durif F; Agid Y
The phenomenology of L-dopa-induced dyskinesias in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1999;14 Suppl 1():13-8.
1999: Vidailhet M; Rivaud S; Gouider-Khouja N; Pillon B; Gaymard B; Agid Y; Kennard C; Pierrot-Deseilligny C
Saccades and antisaccades in parkinsonian syndromes.
Advances in neurology 1999;80():377-82.
1999: Hirsch E C; Hunot S; Damier P; Brugg B; Faucheux B A; Michel P P; Ruberg M; Muriel M P; Mouatt-Prigent A; Agid Y
Glial cell participation in the degeneration of dopaminergic neurons in Parkinson's disease.
Advances in neurology 1999;80():9-18.
1999: Murer M G; Boissiere F; Yan Q; Hunot S; Villares J; Faucheux B; Agid Y; Hirsch E; Raisman-Vozari R
An immunohistochemical study of the distribution of brain-derived neurotrophic factor in the adult human brain, with particular reference to Alzheimer's disease.
Neuroscience 1999;88(4):1015-32.
1998: Sirigu A; Cohen L; Zalla T; Pradat-Diehl P; Van Eeckhout P; Grafman J; Agid Y
Distinct frontal regions for processing sentence syntax and story grammar.
Cortex; a journal devoted to the study of the nervous system and behavior 1998;34(5):771-8.
1998: Picard F; Tassin J; Vidailhet M; Marescaux C; Picard F; Agid Y; Brice A
Autosomal dominant paroxysmal kinesigenic choreoathetosis: a clinical and genetic study of two families.
Journal of neurology, neurosurgery, and psychiatry 1998;65(6):955-6.
1998: Villares J; Faucheux B; Herrero M T; Obeso J A; Duyckaerts C; Hauw J J; Agid Y; Hirsch E C
[125I]EGF binding in basal ganglia of patients with Parkinson's disease and progressive supranuclear palsy and in MPTP-treated monkeys.
Experimental neurology 1998;154(1):146-56.
1998: Bejjani B P; Damier P; Arnulf I; Papadopoulos S; Bonnet A M; Vidailhet M; Agid Y; Pidoux B; Cornu P; Dormont D; Marsault C
Deep brain stimulation in Parkinson's disease: opposite effects of stimulation in the pallidum.
Movement disorders : official journal of the Movement Disorder Society 1998;13(6):969-70.
1998: Brandel J P; Agid Y
[Creutzfeldt-Jakob disease after treatment with growth hormone: the point in July, 1998]
Revue neurologique 1998;154(10):654-5.
1998: Lücking C B; Abbas N; Dürr A; Bonifati V; Bonnet A M; de Broucker T; De Michele G; Wood N W; Agid Y; Brice A
Homozygous deletions in parkin gene in European and North African families with autosomal recessive juvenile parkinsonism. The European Consortium on Genetic Susceptibility in Parkinson's Disease and the French Parkinson's Disease Genetics Study Group.
Lancet 1998;352(9137):1355-6.
1998: Dumanchin C; Camuzat A; Campion D; Verpillat P; Hannequin D; Dubois B; Saugier-Veber P; Martin C; Penet C; Charbonnier F; Agid Y; Frebourg T; Brice A
Segregation of a missense mutation in the microtubule-associated protein tau gene with familial frontotemporal dementia and parkinsonism.
Human molecular genetics 1998;7(11):1825-9.
1998: Benisty S; Boissiere F; Faucheux B; Agid Y; Hirsch E C
trkB messenger RNA expression in normal human brain and in the substantia nigra of parkinsonian patients: an in situ hybridization study.
Neuroscience 1998;86(3):813-26.
1998: Zalla T; Sirigu A; Pillon B; Dubois B; Grafman J; Agid Y
Deficit in evaluating pre-determined sequences of script events in patients with Parkinson's disease.
Cortex; a journal devoted to the study of the nervous system and behavior 1998;34(4):621-7.
1998: Lehéricy S; van de Moortele P F; Lobel E; Paradis A L; Vidailhet M; Frouin V; Neveu P; Agid Y; Marsault C; Le Bihan D
Somatotopical organization of striatal activation during finger and toe movement: a 3-T functional magnetic resonance imaging study.
Annals of neurology 1998;44(3):398-404.
1998: Dumanchin C; Brice A; Campion D; Hannequin D; Martin C; Moreau V; Agid Y; Martinez M; Clerget-Darpoux F; Frebourg T
De novo presenilin 1 mutations are rare in clinically sporadic, early onset Alzheimer's disease cases. French Alzheimer's Disease Study Group.
Journal of medical genetics 1998;35(8):672-3.
1998: Vaughan J; Durr A; Tassin J; Bereznai B; Gasser T; Bonifati V; De Michele G; Fabrizio E; Volpe G; Bandmann O; Johnson W G; Golbe L I; Breteler M; Meco G; Agid Y; Brice A; Marsden C D; Wood N W
The alpha-synuclein Ala53Thr mutation is not a common cause of familial Parkinson's disease: a study of 230 European cases. European Consortium on Genetic Susceptibility in Parkinson's Disease.
Annals of neurology 1998;44(2):270-3.
1998: Boissière F; Faucheux B; Duyckaerts C; Hauw J J; Agid Y; Hirsch E C
Striatal expression of glutamic acid decarboxylase gene in Alzheimer's disease.
Journal of neurochemistry 1998;71(2):767-74.
1998: Litvan I; MacIntyre A; Goetz C G; Wenning G K; Jellinger K; Verny M; Bartko J J; Jankovic J; McKee A; Brandel J P; Chaudhuri K R; Lai E C; D'Olhaberriague L; Pearce R K; Agid Y
Accuracy of the clinical diagnoses of Lewy body disease, Parkinson disease, and dementia with Lewy bodies: a clinicopathologic study.
Archives of neurology 1998;55(7):969-78.
1998: Tassin J; Dürr A; de Broucker T; Abbas N; Bonifati V; De Michele G; Bonnet A M; Broussolle E; Pollak P; Vidailhet M; De Mari M; Marconi R; Medjbeur S; Filla A; Meco G; Agid Y; Brice A
Chromosome 6-linked autosomal recessive early-onset Parkinsonism: linkage in European and Algerian families, extension of the clinical spectrum, and evidence of a small homozygous deletion in one family. The French Parkinson's Disease Genetics Study Group, and the European Consortium on Genetic Susceptibility in Parkinson's Disease.
American journal of human genetics 1998;63(1):88-94.
1998: Gourfinkel-An I; Cancel G; Duyckaerts C; Faucheux B; Hauw J J; Trottier Y; Brice A; Agid Y; Hirsch E C
Neuronal distribution of intranuclear inclusions in Huntington's disease with adult onset.
Neuroreport 1998;9(8):1823-6.
1998: Martinez M; Campion D; Brice A; Hannequin D; Dubois B; Didierjean O; Michon A; Thomas-Anterion C; Puel M; Frebourg T; Agid Y; Clerget-Darpoux F
Apolipoprotein E epsilon4 allele and familial aggregation of Alzheimer disease.
Archives of neurology 1998;55(6):810-6.
1998: Gaymard B; Rivaud S; Cassarini J F; Dubard T; Rancurel G; Agid Y; Pierrot-Deseilligny C
Effects of anterior cingulate cortex lesions on ocular saccades in humans.
Experimental brain research. Experimentelle Hirnforschung. Expérimentation cérébrale 1998;120(2):173-83.
1998: Murer M G; Dziewczapolski G; Menalled L B; García M C; Agid Y; Gershanik O; Raisman-Vozari R
Chronic levodopa is not toxic for remaining dopamine neurons, but instead promotes their recovery, in rats with moderate nigrostriatal lesions.
Annals of neurology 1998;43(5):561-75.
1998: Holmberg M; Duyckaerts C; Dürr A; Cancel G; Gourfinkel-An I; Damier P; Faucheux B; Trottier Y; Hirsch E C; Agid Y; Brice A
Spinocerebellar ataxia type 7 (SCA7): a neurodegenerative disorder with neuronal intranuclear inclusions.
Human molecular genetics 1998;7(5):913-8.
1998: Ballan G; Tison F; Dousset V; Vidailhet M; Agid Y; Henry P
[Study of cortical atrophy with magnetic resonance imaging in corticobasal degeneration]
Revue neurologique 1998;154(3):224-7.
1998: Birouk N; LeGuern E; Maisonobe T; Rouger H; Gouider R; Tardieu S; Gugenheim M; Routon M C; Léger J M; Agid Y; Brice A; Bouche P
X-linked Charcot-Marie-Tooth disease with connexin 32 mutations: clinical and electrophysiologic study.
Neurology 1998;50(4):1074-82.
1998: Agid Y
Levodopa: is toxicity a myth?
Neurology 1998;50(4):858-63.
1998: Vaughan J R; Farrer M J; Wszolek Z K; Gasser T; Durr A; Agid Y; Bonifati V; DeMichele G; Volpe G; Lincoln S; Breteler M; Meco G; Brice A; Marsden C D; Hardy J; Wood N W
Sequencing of the alpha-synuclein gene in a large series of cases of familial Parkinson's disease fails to reveal any further mutations. The European Consortium on Genetic Susceptibility in Parkinson's Disease (GSPD).
Human molecular genetics 1998;7(4):751-3.
1998: Bédard M A; el Massioui F; Malapani C; Dubois B; Pillon B; Renault B; Agid Y
Attentional deficits in Parkinson's disease: partial reversibility with naphtoxazine (SDZ NVI-085), a selective noradrenergic alpha 1 agonist.
Clinical neuropharmacology 1998;21(2):108-17.
1998: Agid Y; Chase T; Marsden D
Adverse reactions to levodopa: drug toxicity or progression of disease?
Lancet 1998;351(9106):851-2.
1998: Rivaud-Pechoux S; Dürr A; Gaymard B; Cancel G; Ploner C J; Agid Y; Brice A; Pierrot-Deseilligny C
Eye movement abnormalities correlate with genotype in autosomal dominant cerebellar ataxia type I.
Annals of neurology 1998;43(3):297-302.
1998: Ploner C J; Gaymard B; Rivaud S; Agid Y; Pierrot-Deseilligny C
Temporal limits of spatial working memory in humans.
The European journal of neuroscience 1998;10(2):794-7.
1998: Ferreira C T; Vérin M; Pillon B; Levy R; Dubois B; Agid Y
Spatio-temporal working memory and frontal lesions in man.
Cortex; a journal devoted to the study of the nervous system and behavior 1998;34(1):83-98.
1998: Hahn-Barma V; Deweer B; Dürr A; Dodé C; Feingold J; Pillon B; Agid Y; Brice A; Dubois B
Are cognitive changes the first symptoms of Huntington's disease? A study of gene carriers.
Journal of neurology, neurosurgery, and psychiatry 1998;64(2):172-7.
1998: Pol S; Vidailhet M; Meunier S; Mazevet D; Agid Y; Pierrot-Deseilligny E
Overactivity of cervical premotor neurons in Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 1998;64(2):166-71.
1998: David G; Dürr A; Stevanin G; Cancel G; Abbas N; Benomar A; Belal S; Lebre A S; Abada-Bendib M; Grid D; Holmberg M; Yahyaoui M; Hentati F; Chkili T; Agid Y; Brice A
Molecular and clinical correlations in autosomal dominant cerebellar ataxia with progressive macular dystrophy (SCA7).
Human molecular genetics 1998;7(2):165-70.
1998: Vidailhet M; Bonnet A M; Agid Y
[Clinical diagnostic criteria for multiple system atrophy]
Revue neurologique 1998;154(1):17-21.
1998: Hannequin D; Campion D; Dumanchin C; Martinez M; Agid Y; Clerget-Darpoux F; Frebourg T; Brice A
[Genetics of Alzheimer's disease]
Revue neurologique 1998;154 Suppl 2():S65-74.
1998: Vidailhet M; Jedynak C P; Pollak P; Agid Y
Pathology of symptomatic tremors.
Movement disorders : official journal of the Movement Disorder Society 1998;13 Suppl 3():49-54.
1998: Litvan I; Booth V; Wenning G K; Bartko J J; Goetz C G; McKee A; Jankovic J; Jellinger K; Lai E C; Brandel J P; Verny M; Chaudhuri K R; Pearce R K; Agid Y
Retrospective application of a set of clinical diagnostic criteria for the diagnosis of multiple system atrophy.
Journal of neural transmission (Vienna, Austria : 1996) 1998;105(2-3):217-27.
1998: Cancel G; Gourfinkel-An I; Stevanin G; Didierjean O; Abbas N; Hirsch E; Agid Y; Brice A
Somatic mosaicism of the CAG repeat expansion in spinocerebellar ataxia type 3/Machado-Joseph disease.
Human mutation 1998;11(1):23-7.
1997: Bejjani B; Damier P; Arnulf I; Bonnet A M; Vidailhet M; Dormont D; Pidoux B; Cornu P; Marsault C; Agid Y
Pallidal stimulation for Parkinson's disease. Two targets?
Neurology 1997;49(6):1564-9.
1997: Gourfinkel-An I; Cancel G; Trottier Y; Devys D; Tora L; Lutz Y; Imbert G; Saudou F; Stevanin G; Agid Y; Brice A; Mandel J L; Hirsch E C
Differential distribution of the normal and mutated forms of huntingtin in the human brain.
Annals of neurology 1997;42(5):712-9.
1997: Stevanin G; Dürr A; David G; Didierjean O; Cancel G; Rivaud S; Tourbah A; Warter J M; Agid Y; Brice A
Clinical and molecular features of spinocerebellar ataxia type 6.
Neurology 1997;49(5):1243-6.
1997: France-Lanord V; Brugg B; Michel P P; Agid Y; Ruberg M
Mitochondrial free radical signal in ceramide-dependent apoptosis: a putative mechanism for neuronal death in Parkinson's disease.
Journal of neurochemistry 1997;69(4):1612-21.
1997: Michel P P; Ruberg M; Agid Y
Rescue of mesencephalic dopamine neurons by anticancer drug cytosine arabinoside.
Journal of neurochemistry 1997;69(4):1499-507.
1997: Ruberg M; France-Lanord V; Brugg B; Lambeng N; Michel P P; Anglade P; Hunot S; Damier P; Faucheux B; Hirsch E; Agid Y
[Neuronal death caused by apoptosis in Parkinson disease]
Revue neurologique 1997;153(8-9):499-508.
1997: Boissière F; Hunot S; Faucheux B; Duyckaerts C; Hauw J J; Agid Y; Hirsch E C
Nuclear translocation of NF-kappaB in cholinergic neurons of patients with Alzheimer's disease.
Neuroreport 1997;8(13):2849-52.
1997: Agid Y; Destée A; Durif F; Montastruc J L; Pollak P
Tolcapone, bromocriptine, and Parkinson's disease. French Tolcapone Study Group.
Lancet 1997;350(9079):712-3.
1997: David G; Abbas N; Stevanin G; Dürr A; Yvert G; Cancel G; Weber C; Imbert G; Saudou F; Antoniou E; Drabkin H; Gemmill R; Giunti P; Benomar A; Wood N; Ruberg M; Agid Y; Mandel J L; Brice A
Cloning of the SCA7 gene reveals a highly unstable CAG repeat expansion.
Nature genetics 1997;17(1):65-70.
1997: Murer G; Adelbrecht C; Lauritzen I; Lesage F; Lazdunski M; Agid Y; Raisman-Vozari R
An immunocytochemical study on the distribution of two G-protein-gated inward rectifier potassium channels (GIRK2 and GIRK4) in the adult rat brain.
Neuroscience 1997;80(2):345-57.
1997: Litvan I; Goetz C G; Jankovic J; Wenning G K; Booth V; Bartko J J; McKee A; Jellinger K; Lai E C; Brandel J P; Verny M; Chaudhuri K R; Pearce R K; Agid Y
What is the accuracy of the clinical diagnosis of multiple system atrophy? A clinicopathologic study.
Archives of neurology 1997;54(8):937-44.
1997: Gasser T; Müller-Myhsok B; Wszolek Z K; Dürr A; Vaughan J R; Bonifati V; Meco G; Bereznai B; Oehlmann R; Agid Y; Brice A; Wood N
Genetic complexity and Parkinson's disease.
Science (New York, N.Y.) 1997;277(5324):388-9; author reply 389.
1997: Bonnet A M; Pichon J; Vidailhet M; Gouider-Khouja N; Robain G; Perrigot M; Agid Y
Urinary disturbances in striatonigral degeneration and Parkinson's disease: clinical and urodynamic aspects.
Movement disorders : official journal of the Movement Disorder Society 1997;12(4):509-13.
1997: Anglade P; Vyas S; Hirsch E C; Agid Y
Apoptosis in dopaminergic neurons of the human substantia nigra during normal aging.
Histology and histopathology 1997;12(3):603-10.
1997: Litvan I; Agid Y; Sastry N; Jankovic J; Wenning G K; Goetz C G; Verny M; Brandel J P; Jellinger K; Chaudhuri K R; McKee A; Lai E C; Pearce R K; Bartko J J;
What are the obstacles for an accurate clinical diagnosis of Pick's disease? A clinicopathologic study.
Neurology 1997;49(1):62-9.
1997: Didierjean O; Martinez M; Campion D; Hannequin D; Dubois B; Martin C; Puel M; Thomas Anterion C; Pasquier F; Moreau O; Babron M C; Penet C; Agid Y; Clerget-Darpoux F; Frebourg T; Brice A
No effect of the alpha1-antichymotrypsin A allele in Alzheimer's disease.
Journal of neurology, neurosurgery, and psychiatry 1997;63(1):103-5.
1997: Hunot S; Brugg B; Ricard D; Michel P P; Muriel M P; Ruberg M; Faucheux B A; Agid Y; Hirsch E C
Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with parkinson disease.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(14):7531-6.
1997: Vyas S; Javoy-Agid F; Herrero M T; Strada O; Boissiere F; Hibner U; Agid Y
Expression of Bcl-2 in adult human brain regions with special reference to neurodegenerative disorders.
Journal of neurochemistry 1997;69(1):223-31.
1997: Stevanin G; Lebre A S; Mathieux C; Cancel G; Abbas N; Didierjean O; Dürr A; Trottier Y; Agid Y; Brice A
Linkage disequilibrium between the spinocerebellar ataxia 3/Machado-Joseph disease mutation and two intragenic polymorphisms, one of which, X359Y, affects the stop codon.
American journal of human genetics 1997;60(6):1548-52.
1997: Dormont D; Cornu P; Pidoux B; Bonnet A M; Biondi A; Oppenheim C; Hasboun D; Damier P; Cuchet E; Philippon J; Agid Y; Marsault C
Chronic thalamic stimulation with three-dimensional MR stereotactic guidance.
AJNR. American journal of neuroradiology 1997;18(6):1093-107.
1997: Boissiere F; Faucheux B; Ruberg M; Agid Y; Hirsch E C
Decreased TrkA gene expression in cholinergic neurons of the striatum and basal forebrain of patients with Alzheimer's disease.
Experimental neurology 1997;145(1):245-52.
1997: Birouk N; Gouider R; Le Guern E; Gugenheim M; Tardieu S; Maisonobe T; Le Forestier N; Agid Y; Brice A; Bouche P
Charcot-Marie-Tooth disease type 1A with 17p11.2 duplication. Clinical and electrophysiological phenotype study and factors influencing disease severity in 119 cases.
Brain : a journal of neurology 1997;120 ( Pt 5)():813-23.
1997: Cancel G; Dürr A; Didierjean O; Imbert G; Bürk K; Lezin A; Belal S; Benomar A; Abada-Bendib M; Vial C; Guimarães J; Chneiweiss H; Stevanin G; Yvert G; Abbas N; Saudou F; Lebre A S; Yahyaoui M; Hentati F; Vernant J C; Klockgether T; Mandel J L; Agid Y; Brice A
Molecular and clinical correlations in spinocerebellar ataxia 2: a study of 32 families.
Human molecular genetics 1997;6(5):709-15.
1997: Ruberg M; Brugg B; Prigent A; Hirsch E; Brice A; Agid Y
Is differential regulation of mitochondrial transcripts in Parkinson's disease related to apoptosis?
Journal of neurochemistry 1997;68(5):2098-110.
1997: Boissière F; Faucheux B; Agid Y; Hirsch E C
Choline acetyltransferase mRNA expression in the striatal neurons of patients with Alzheimer's disease.
Neuroscience letters 1997;225(3):169-72.
1997: Dziewczapolski G; Murer G; Agid Y; Gershanik O; Raisman-Vozari R
Absence of neurotoxicity of chronic L-DOPA in 6-hydroxydopamine-lesioned rats.
Neuroreport 1997;8(4):975-9.
1997: Adelbrecht C; Murer M G; Lauritzen I; Lesage F; Ladzunski M; Agid Y; Raisman-Vozari R
An immunocytochemical study of a G-protein-gated inward rectifier K+ channel (GIRK2) in the weaver mouse mesencephalon.
Neuroreport 1997;8(4):969-74.
1997: Durif F; Vidailhet M; Assal F; Roche C; Bonnet A M; Agid Y
Low-dose clozapine improves dyskinesias in Parkinson's disease.
Neurology 1997;48(3):658-62.
1997: Faucheux B A; Hauw J J; Agid Y; Hirsch E C
The density of [125I]-transferrin binding sites on perikarya of melanized neurons of the substantia nigra is decreased in Parkinson's disease.
Brain research 1997;749(1):170-4.
1997: Bickeböller H; Campion D; Brice A; Amouyel P; Hannequin D; Didierjean O; Penet C; Martin C; Pérez-Tur J; Michon A; Dubois B; Ledoze F; Thomas-Anterion C; Pasquier F; Puel M; Demonet J F; Moreaud O; Babron M C; Meulien D; Guez D; Chartier-Harlin M C; Frebourg T; Agid Y; Martinez M; Clerget-Darpoux F
Apolipoprotein E and Alzheimer disease: genotype-specific risks by age and sex.
American journal of human genetics 1997;60(2):439-46.
1997: Boissière F; Faucheux B; Agid Y; Hirsch E C
Expression of catalytic trkB gene in the striatum and the basal forebrain of patients with Alzheimer's disease: an in situ hybridization study.
Neuroscience letters 1997;221(2-3):141-4.
1997: Anglade P; Vyas S; Javoy-Agid F; Herrero M T; Michel P P; Marquez J; Mouatt-Prigent A; Ruberg M; Hirsch E C; Agid Y
Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease.
Histology and histopathology 1997;12(1):25-31.
1997: Levy R; Hazrati L N; Herrero M T; Vila M; Hassani O K; Mouroux M; Ruberg M; Asensi H; Agid Y; Féger J; Obeso J A; Parent A; Hirsch E C
Re-evaluation of the functional anatomy of the basal ganglia in normal and Parkinsonian states.
Neuroscience 1997;76(2):335-43.
1997: Litvan I; Agid Y; Goetz C; Jankovic J; Wenning G K; Brandel J P; Lai E C; Verny M; Ray-Chaudhuri K; McKee A; Jellinger K; Pearce R K; Bartko J J
Accuracy of the clinical diagnosis of corticobasal degeneration: a clinicopathologic study.
Neurology 1997;48(1):119-25.
1997: Boissière F; Hunot S; Faucheux B; Hersh L B; Agid Y; Hirsch E C
Trk neurotrophin receptors in cholinergic neurons of patients with Alzheimer's disease.
Dementia and geriatric cognitive disorders 1997;8(1):1-8.
1997: Vila M; Levy R; Herrero M T; Ruberg M; Faucheux B; Obeso J A; Agid Y; Hirsch E C
Consequences of nigrostriatal denervation on the functioning of the basal ganglia in human and nonhuman primates: an in situ hybridization study of cytochrome oxidase subunit I mRNA.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1997;17(2):765-73.
1997: Rouger H; LeGuern E; Birouk N; Gouider R; Tardieu S; Plassart E; Gugenheim M; Vallat J M; Louboutin J P; Bouche P; Agid Y; Brice A
Charcot-Marie-Tooth disease with intermediate motor nerve conduction velocities: characterization of 14 Cx32 mutations in 35 families.
Human mutation 1997;10(6):443-52.
1997: Hirsch E C; Faucheux B; Damier P; Mouatt-Prigent A; Agid Y
Neuronal vulnerability in Parkinson's disease.
Journal of neural transmission. Supplementum 1997;50():79-88.
1996: Brice A; Dubois B; Agid Y; Campion D; Martinez M; Clerger-Darpoux F; Bellis M; Mallet J; Frebourg T; Hannequin D; Puel M; Ledoze F; Pasquier F; Zimmerman M A; Thomas-Anterion C; Moreaud O; Goas J Y
[Genetics of dominant autosomal forms of Alzheimer disease: 3 genes and one phenotype. Groupe de Recherche Francais sur la Maladie d'Alzheimer]
Revue neurologique 1996;152(12):725-6.
1996: Adelbrecht C; Agid Y; Raisman-Vozari R
Effect of the weaver mutation on the expression of dopamine membrane transporter, tyrosine hydroxylase and vesicular monoamine transporter in dopaminergic neurons of the substantia nigra and the ventral tegmental area.
Brain research. Molecular brain research 1996;43(1-2):291-300.
1996: Pezzoli G; Strada O; Silani V; Zecchinelli A; Perbellini L; Javoy-Agid F; Ghidoni P; Motti E D; Masini T; Scarlato G; Agid Y; Hirsch E C
Clinical and pathological features in hydrocarbon-induced parkinsonism.
Annals of neurology 1996;40(6):922-5.
1996: Chritin M; Blanchard V; Raisman-Vozari R; Feuerstein C; Agid Y; Javoy-Agid F; Savasta M
DA uptake sites, D1 and D2 receptors, D2 and preproenkephalin mRNAs and Fos immunoreactivity in rat striatal subregions after partial dopaminergic degeneration.
The European journal of neuroscience 1996;8(12):2511-20.
1996: Stevanin G; Trottier Y; Cancel G; Dürr A; David G; Didierjean O; Bürk K; Imbert G; Saudou F; Abada-Bendib M; Gourfinkel-An I; Benomar A; Abbas N; Klockgether T; Grid D; Agid Y; Mandel J L; Brice A
Screening for proteins with polyglutamine expansions in autosomal dominant cerebellar ataxias.
Human molecular genetics 1996;5(12):1887-92.
1996: David G; Giunti P; Abbas N; Coullin P; Stevanin G; Horta W; Gemmill R; Weissenbach J; Wood N; Cunha S; Drabkin H; Harding A E; Agid Y; Brice A
The gene for autosomal dominant cerebellar ataxia type II is located in a 5-cM region in 3p12-p13: genetic and physical mapping of the SCA7 locus.
American journal of human genetics 1996;59(6):1328-36.
1996: Herrero M T; Augood S J; Asensi H; Hirsch E C; Agid Y; Obeso J A; Emson P C
Effects of L-DOPA-therapy on dopamine D2 receptor mRNA expression in the striatum of MPTP-intoxicated parkinsonian monkeys.
Brain research. Molecular brain research 1996;42(1):149-55.
1996: Imbert G; Saudou F; Yvert G; Devys D; Trottier Y; Garnier J M; Weber C; Mandel J L; Cancel G; Abbas N; Dürr A; Didierjean O; Stevanin G; Agid Y; Brice A
Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with high sensitivity to expanded CAG/glutamine repeats.
Nature genetics 1996;14(3):285-91.
1996: Guridi J; Herrero M T; Luquin M R; Guillén J; Ruberg M; Laguna J; Vila M; Javoy-Agid F; Agid Y; Hirsch E; Obeso J A
Subthalamotomy in parkinsonian monkeys. Behavioural and biochemical analysis.
Brain : a journal of neurology 1996;119 ( Pt 5)():1717-27.
1996: Michel P P; Agid Y
Chronic activation of the cyclic AMP signaling pathway promotes development and long-term survival of mesencephalic dopaminergic neurons.
Journal of neurochemistry 1996;67(4):1633-42.
1996: Dürr A; Cossee M; Agid Y; Campuzano V; Mignard C; Penet C; Mandel J L; Brice A; Koenig M
Clinical and genetic abnormalities in patients with Friedreich's ataxia.
The New England journal of medicine 1996;335(16):1169-75.
1996: Agid Y; Hirsch E; Anglade P; Michel P; Brugg B; Ruberg M
Aging, disease and death of nerve cells.
Acta neurologica Belgica 1996;96(3):219-23.
1996: Billette de Villemeur T; Deslys J P; Pradel A; Soubrié C; Alpérovitch A; Tardieu M; Chaussain J L; Hauw J J; Dormont D; Ruberg M; Agid Y
Creutzfeldt-Jakob disease from contaminated growth hormone extracts in France.
Neurology 1996;47(3):690-5.
1996: Sirigu A; Duhamel J R; Cohen L; Pillon B; Dubois B; Agid Y
The mental representation of hand movements after parietal cortex damage.
Science (New York, N.Y.) 1996;273(5281):1564-8.
1996: Boissière F; Pradier L; Delaère P; Faucheux B; Revah F; Brice A; Agid Y; Hirsch E C
Regional and cellular presenilin 2 (STM2) gene expression in the human brain.
Neuroreport 1996;7(12):2021-5.
1996: Campion D; Brice A; Hannequin D; Charbonnier F; Dubois B; Martin C; Michon A; Penet C; Bellis M; Calenda A; Martinez M; Agid Y; Clerget-Darpoux F; Frebourg T
No founder effect in three novel Alzheimer's disease families with APP 717 Val-->Ile mutation. Clerget-darpoux. French Alzheimer's Disease Study Group.
Journal of medical genetics 1996;33(8):661-4.
1996: Verny M; Duyckaerts C; Agid Y; Hauw J J
The significance of cortical pathology in progressive supranuclear palsy. Clinico-pathological data in 10 cases.
Brain : a journal of neurology 1996;119 ( Pt 4)():1123-36.
1996: Mouatt-Prigent A; Karlsson J O; Agid Y; Hirsch E C
Increased M-calpain expression in the mesencephalon of patients with Parkinson's disease but not in other neurodegenerative disorders involving the mesencephalon: a role in nerve cell death?
Neuroscience 1996;73(4):979-87.
1996: Campion D; Brice A; Dumanchin C; Puel M; Baulac M; De La Sayette V; Hannequin D; Duyckaerts C; Michon A; Martin C; Moreau V; Penet C; Martinez M; Clerget-Darpoux F; Agid Y; Frebourg T
A novel presenilin 1 mutation resulting in familial Alzheimer's disease with an onset age of 29 years.
Neuroreport 1996;7(10):1582-4.
1996: Sherrington R; Froelich S; Sorbi S; Campion D; Chi H; Rogaeva E A; Levesque G; Rogaev E I; Lin C; Liang Y; Ikeda M; Mar L; Brice A; Agid Y; Percy M E; Clerget-Darpoux F; Piacentini S; Marcon G; Nacmias B; Amaducci L; Frebourg T; Lannfelt L; Rommens J M; St George-Hyslop P H
Alzheimer's disease associated with mutations in presenilin 2 is rare and variably penetrant.
Human molecular genetics 1996;5(7):985-8.
1996: Igarashi S; Takiyama Y; Cancel G; Rogaeva E A; Sasaki H; Wakisaka A; Zhou Y X; Takano H; Endo K; Sanpei K; Oyake M; Tanaka H; Stevanin G; Abbas N; Dürr A; Rogaev E I; Sherrington R; Tsuda T; Ikeda M; Cassa E; Nishizawa M; Benomar A; Julien J; Weissenbach J; Wang G X; Agid Y; St George-Hyslop P H; Brice A; Tsuji S
Intergenerational instability of the CAG repeat of the gene for Machado-Joseph disease (MJD1) is affected by the genotype of the normal chromosome: implications for the molecular mechanisms of the instability of the CAG repeat.
Human molecular genetics 1996;5(7):923-32.
1996: Partiot A; Vérin M; Pillon B; Teixeira-Ferreira C; Agid Y; Dubois B
Delayed response tasks in basal ganglia lesions in man: further evidence for a striato-frontal cooperation in behavioural adaptation.
Neuropsychologia 1996;34(7):709-21.
1996: Herrero M T; Levy R; Ruberg M; Luquin M R; Villares J; Guillen J; Faucheux B; Javoy-Agid F; Guridi J; Agid Y; Obeso J A; Hirsch E C
Consequence of nigrostriatal denervation and L-dopa therapy on the expression of glutamic acid decarboxylase messenger RNA in the pallidum.
Neurology 1996;47(1):219-24.
1996: Litvan I; Agid Y; Calne D; Campbell G; Dubois B; Duvoisin R C; Goetz C G; Golbe L I; Grafman J; Growdon J H; Hallett M; Jankovic J; Quinn N P; Tolosa E; Zee D S
Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop.
Neurology 1996;47(1):1-9.
1996: Anglade P; Mouatt-Prigent A; Agid Y; Hirsch E
Synaptic plasticity in the caudate nucleus of patients with Parkinson's disease.
Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration 1996;5(2):121-8.
1996: Sirigu A; Zalla T; Pillon B; Grafman J; Agid Y; Dubois B
Encoding of sequence and boundaries of scripts following prefrontal lesions.
Cortex; a journal devoted to the study of the nervous system and behavior 1996;32(2):297-310.
1996: Lopes J; LeGuern E; Gouider R; Tardieu S; Abbas N; Birouk N; Gugenheim M; Bouche P; Agid Y; Brice A
Recombination hot spot in a 3.2-kb region of the Charcot-Marie-Tooth type 1A repeat sequences: new tools for molecular diagnosis of hereditary neuropathy with liability to pressure palsies and of Charcot-Marie-Tooth type 1A. French CMT Collaborative Research Group.
American journal of human genetics 1996;58(6):1223-30.
1996: Carpentier A F; Bonnet A M; Vidailhet M; Agid Y
Improvement of levodopa-induced dyskinesia by propranolol in Parkinson's disease.
Neurology 1996;46(6):1548-51.
1996: Boissière F; Lehéricy S; Strada O; Agid Y; Hirsch E C
Neurotrophin receptors and selective loss of cholinergic neurons in Alzheimer disease.
Molecular and chemical neuropathology / sponsored by the International Society for Neurochemistry and the World Federation of Neurology and research groups on neurochemistry and cerebrospinal fluid 1996;28(1-3):219-23.
1996: Bernard V; Gardiol A; Faucheux B; Bloch B; Agid Y; Hirsch E C
Expression of glutamate receptors in the human and rat basal ganglia: effect of the dopaminergic denervation on AMPA receptor gene expression in the striatopallidal complex in Parkinson's disease and rat with 6-OHDA lesion.
The Journal of comparative neurology 1996;368(4):553-68.
1996: Hunot S; Boissière F; Faucheux B; Brugg B; Mouatt-Prigent A; Agid Y; Hirsch E C
Nitric oxide synthase and neuronal vulnerability in Parkinson's disease.
Neuroscience 1996;72(2):355-63.
1996: Brandel J P; Vidailhet M; Noseda G; Harpey J P; Agid Y
Mycoplasma pneumoniae postinfectious encephalomyelitis with bilateral striatal necrosis.
Movement disorders : official journal of the Movement Disorder Society 1996;11(3):333-6.
1996: Lezin A; Cancel G; Stevanin G; Smadja D; Vernant J C; Dürr A; Martial J; Buisson G G; Bellance R; Chneiweiss H; Agid Y; Brice A
Autosomal dominant cerebellar ataxia type I in Martinique (French West Indies): genetic analysis of three unrelated SCA2 families.
Human genetics 1996;97(5):671-6.
1996: Damier P; Kastner A; Agid Y; Hirsch E C
Does monoamine oxidase type B play a role in dopaminergic nerve cell death in Parkinson's disease?
Neurology 1996;46(5):1262-9.
1996: Litvan I; Agid Y; Jankovic J; Goetz C; Brandel J P; Lai E C; Wenning G; D'Olhaberriague L; Verny M; Chaudhuri K R; McKee A; Jellinger K; Bartko J J; Mangone C A; Pearce R K
Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome).
Neurology 1996;46(4):922-30.
1996: Vila M; Levy R; Herrero M T; Faucheux B; Obeso J A; Agid Y; Hirsch E C
Metabolic activity of the basal ganglia in parkinsonian syndromes in human and non-human primates: a cytochrome oxidase histochemistry study.
Neuroscience 1996;71(4):903-12.
1996: Dürr A; Stevanin G; Cancel G; Duyckaerts C; Abbas N; Didierjean O; Chneiweiss H; Benomar A; Lyon-Caen O; Julien J; Serdaru M; Penet C; Agid Y; Brice A
Spinocerebellar ataxia 3 and Machado-Joseph disease: clinical, molecular, and neuropathological features.
Annals of neurology 1996;39(4):490-9.
1996: Lehéricy S; Vidailhet M; Dormont D; Piérot L; Chiras J; Mazetti P; Marsault C; Agid Y
Striatopallidal and thalamic dystonia. A magnetic resonance imaging anatomoclinical study.
Archives of neurology 1996;53(3):241-50.
1996: Rouger H; LeGuern E; Gouider R; Tardieu S; Birouk N; Gugenheim M; Bouche P; Agid Y; Brice A
High frequency of mutations in codon 98 of the peripheral myelin protein P0 gene in 20 French CMT1 patients.
American journal of human genetics 1996;58(3):638-41.
1996: Vila M; Herrero M T; Levy R; Faucheux B; Ruberg M; Guillen J; Luquin M R; Guridi J; Javoy-Agid F; Agid Y; Obeso J A; Hirsch E C
Consequences of nigrostriatal denervation on the gamma-aminobutyric acidic neurons of substantia nigra pars reticulata and superior colliculus in parkinsonian syndromes.
Neurology 1996;46(3):802-9.
1996: Blanchard V; Anglade P; Dziewczapolski G; Savasta M; Agid Y; Raisman-Vozari R
Dopaminergic sprouting in the rat striatum after partial lesion of the substantia nigra.
Brain research 1996;709(2):319-25.
1996: Vermersch A I; Müri R M; Rivaud S; Vidailhet M; Gaymard B; Agid Y; Pierrot-Deseilligny C
Saccade disturbances after bilateral lentiform nucleus lesions in humans.
Journal of neurology, neurosurgery, and psychiatry 1996;60(2):179-84.
1996: Martinez M; Campion D; Babron M C; Hannequin D; Agid Y; Bellis M; Brice A; Mallet J; Michon A; Thomas-Anterion C; Clerget-Darpoux F
Segregation analysis of Alzheimer pedigrees: rare Mendelian dominant mutation(s) explain a minority of early-onset cases. French Alzheimer Collaborative Group.
American journal of medical genetics 1996;67(1):9-12.
1996: Pillon B; Dubois B; Agid Y
Testing cognition may contribute to the diagnosis of movement disorders.
Neurology 1996;46(2):329-34.
1996: Brugg B; Michel P P; Agid Y; Ruberg M
Ceramide induces apoptosis in cultured mesencephalic neurons.
Journal of neurochemistry 1996;66(2):733-9.
1996: Pillon B; Ertle S; Deweer B; Sarazin M; Agid Y; Dubois B
Memory for spatial location is affected in Parkinson's disease.
Neuropsychologia 1996;34(1):77-85.
1996: LeGuern E; Gouider R; Ravisé N; Lopes J; Tardieu S; Gugenheim M; Abbas N; Bouche P; Agid Y; Brice A
A de novo case of hereditary neuropathy with liability to pressure palsies (HNPP) of maternal origin: a new mechanism for deletion in 17p11.2?
Human molecular genetics 1996;5(1):103-6.
1996: Hunot S; Bernard V; Faucheux B; Boissière F; Leguern E; Brana C; Gautris P P; Guérin J; Bloch B; Agid Y; Hirsch E C
Glial cell line-derived neurotrophic factor (GDNF) gene expression in the human brain: a post mortem in situ hybridization study with special reference to Parkinson's disease.
Journal of neural transmission (Vienna, Austria : 1996) 1996;103(8-9):1043-52.
1996: Verny M; Jellinger K A; Hauw J J; Bancher C; Litvan I; Agid Y
Progressive supranuclear palsy: a clinicopathological study of 21 cases.
Acta neuropathologica 1996;91(4):427-31.
1996: Hannequin D; Campion D; Brice A; Frebourg T; Martinez M; Clerget-Darpoux F; Agid Y
[Genetics of Alzheimer's disease]
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 1996;17(7):545-50.
1996: Pillon B; Dubois B; Agid Y
Cognitive deficits in non-Alzheimer's degenerative diseases.
Journal of neural transmission. Supplementum 1996;47():61-71.
1996: Leveugle B; Faucheux B A; Bouras C; Nillesse N; Spik G; Hirsch E C; Agid Y; Hof P R
Cellular distribution of the iron-binding protein lactotransferrin in the mesencephalon of Parkinson's disease cases.
Acta neuropathologica 1996;91(6):566-72.
1996: Herrero M T; Levy R; Ruberg M; Javoy-Agid F; Luquin M R; Agid Y; Hirsch E C; Obeso J A
Glutamic acid decarboxylase mRNA expression in medial and lateral pallidal neurons in the MPTP-treated monkey and patients with Parkinson's disease.
Advances in neurology 1996;69():209-16.
1996: Anglade P; Blanchard V; Raisman-Vozari R; Faucheux B A; Herrero M T; Obeso J A; Mouatt-Prigent A; Kastner A; Strada O; Javoy-Agid F; Agid Y; Hirsch E C
Is dopaminergic cell death accompanied by concomitant nerve plasticity?
Advances in neurology 1996;69():195-208.
1996: LeGuern E; Ravise N; Gouider R; Gugenheim M; Lopes J; Bouche P; Agid Y; Brice A
Microsatellite mapping of the deletion in patients with hereditary neuropathy with liability to pressure palsies (HNPP): new molecular tools for the study of the region 17p12 --> p11 and for diagnosis.
Cytogenetics and cell genetics 1996;72(1):20-5.
1995: Pérez-Tur J; Campion D; Martinez M; Brice A; Tardieu S; Hannequin D; Agid Y; Delacourte A; Clerget-Darpoux F; Chartier-Harlin M C
Evidence for apolipoprotein E epsilon 4 association in early-onset Alzheimer's patients with late-onset relatives.
American journal of medical genetics 1995;60(6):550-3.
1995: Hannequin D; Campion D; Tardieu S; Auzou P; Martinez M; Dubois B; Clerget-Darpoux F; Agid Y; Brice A
[Phenotype of familial forms of early-onset Alzheimer's disease linked to chromosome 14. Clinical and neuropsychological characteristics of a large group]
Revue neurologique 1995;151(12):682-90.
1995: Blin J; Mazetti P; Mazoyer B; Rivaud S; Ben Ayed S; Malapani C; Pillon B; Agid Y
Does the enhancement of cholinergic neurotransmission influence brain glucose kinetics and clinical symptomatology in progressive supranuclear palsy?
Brain : a journal of neurology 1995;118 ( Pt 6)():1485-95.
1995: Dubois B; Levy R; Verin M; Teixeira C; Agid Y; Pillon B
Experimental approach to prefrontal functions in humans.
Annals of the New York Academy of Sciences 1995;769():41-60.
1995: Sirigu A; Zalla T; Pillon B; Grafman J; Dubois B; Agid Y
Planning and script analysis following prefrontal lobe lesions.
Annals of the New York Academy of Sciences 1995;769():277-88.
1995: Remy P; Hosseini H; Degos J D; Samson Y; Agid Y; Warter J M; Vidailhet M
Striatal dopaminergic denervation in pallidopyramidal disease demonstrated by positron emission tomography.
Annals of neurology 1995;38(6):954-6.
1995: Dubourg O; Dürr A; Chneiweiss H; Stevanin G; Cancel G; Penet C; Agid Y; Brice A
[Does the ataxo-choreic form of DRPLA exist in Europe? Search of mutation in 120 families]
Revue neurologique 1995;151(11):657-60.
1995: Gouider R; LeGuern E; Gugenheim M; Tardieu S; Maisonobe T; Léger J M; Vallat J M; Agid Y; Bouche P; Brice A
Clinical, electrophysiologic, and molecular correlations in 13 families with hereditary neuropathy with liability to pressure palsies and a chromosome 17p11.2 deletion.
Neurology 1995;45(11):2018-23.
1995: Stevanin G; Cancel G; Didierjean O; Dürr A; Abbas N; Cassa E; Feingold J; Agid Y; Brice A
Linkage disequilibrium at the Machado-Joseph disease/spinal cerebellar ataxia 3 locus: evidence for a common founder effect in French and Portuguese-Brazilian families as well as a second ancestral Portuguese-Azorean mutation.
American journal of human genetics 1995;57(5):1247-50.
1995: Levy R; Vila M; Herrero M T; Faucheux B; Agid Y; Hirsch E C
Striatal expression of substance P and methionin-enkephalin in genes in patients with Parkinson's disease.
Neuroscience letters 1995;199(3):220-4.
1995: Stevanin G; Cassa E; Cancel G; Abbas N; Dürr A; Jardim E; Agid Y; Sousa P S; Brice A
Characterisation of the unstable expanded CAG repeat in the MJD1 gene in four Brazilian families of Portuguese descent with Machado-Joseph disease.
Journal of medical genetics 1995;32(10):827-30.
1995: Cancel G; Stevanin G; Dürr A; Chneiweiss H; Penet C; Pothin Y; Agid Y; Brice A
SCA2 is not a major locus for ADCA type I in French families.
American journal of medical genetics 1995;60(5):382-5.
1995: Herrero M T; Augood S J; Hirsch E C; Javoy-Agid F; Luquin M R; Agid Y; Obeso J A; Emson P C
Effects of L-DOPA on preproenkephalin and preprotachykinin gene expression in the MPTP-treated monkey striatum.
Neuroscience 1995;68(4):1189-98.
1995: Cancel G; Abbas N; Stevanin G; Dürr A; Chneiweiss H; Néri C; Duyckaerts C; Penet C; Cann H M; Agid Y
Marked phenotypic heterogeneity associated with expansion of a CAG repeat sequence at the spinocerebellar ataxia 3/Machado-Joseph disease locus.
American journal of human genetics 1995;57(4):809-16.
1995: Faucheux B A; Nillesse N; Damier P; Spik G; Mouatt-Prigent A; Pierce A; Leveugle B; Kubis N; Hauw J J; Agid Y
Expression of lactoferrin receptors is increased in the mesencephalon of patients with Parkinson disease.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(21):9603-7.
1995: Dürr A; Stevanin G; Cancel G; Abbas N; Chneiweiss H; Agid Y; Feingold J; Brice A
Gender equality in Machado-Joseph disease.
Nature genetics 1995;11(2):118-9.
1995: Durif F; Vidailhet M; Bonnet A M; Blin J; Agid Y
Levodopa-induced dyskinesias are improved by fluoxetine.
Neurology 1995;45(10):1855-8.
1995: Faucheux B A; Herrero M T; Villares J; Levy R; Javoy-Agid F; Obeso J A; Hauw J J; Agid Y; Hirsch E C
Autoradiographic localization and density of [125I]ferrotransferrin binding sites in the basal ganglia of control subjects, patients with Parkinson's disease and MPTP-lesioned monkeys.
Brain research 1995;691(1-2):115-24.
1995: Bonnet A M; Serre I; Marconi R; Agid Y; Dubois B
A "combined" levodopa test as a useful method for evaluating the efficacy of dopamine agonists: application to pergolide and bromocriptine.
Movement disorders : official journal of the Movement Disorder Society 1995;10(5):668-71.
1995: Thibaut F; Faucheux B A; Marquez J; Villares J; Menard J F; Agid Y; Hirsch E C
Regional distribution of monoamine vesicular uptake sites in the mesencephalon of control subjects and patients with Parkinson's disease: a postmortem study using tritiated tetrabenazine.
Brain research 1995;692(1-2):233-43.
1995: Pillon B; Blin J; Vidailhet M; Deweer B; Sirigu A; Dubois B; Agid Y
The neuropsychological pattern of corticobasal degeneration: comparison with progressive supranuclear palsy and Alzheimer's disease.
Neurology 1995;45(8):1477-83.
1995: Agid Y
[Aging, disease and nerve cell death]
Bulletin de l'Académie nationale de médecine 1995;179(6):1193-203; discussion 1203-7.
1995: Sirigu A; Zalla T; Pillon B; Grafman J; Agid Y; Dubois B
Selective impairments in managerial knowledge following pre-frontal cortex damage.
Cortex; a journal devoted to the study of the nervous system and behavior 1995;31(2):301-16.
1995: Deweer B; Lehéricy S; Pillon B; Baulac M; Chiras J; Marsault C; Agid Y; Dubois B
Memory disorders in probable Alzheimer's disease: the role of hippocampal atrophy as shown with MRI.
Journal of neurology, neurosurgery, and psychiatry 1995;58(5):590-7.
1995: Gouider-Khouja N; Vidailhet M; Bonnet A M; Pichon J; Agid Y
"Pure" striatonigral degeneration and Parkinson's disease: a comparative clinical study.
Movement disorders : official journal of the Movement Disorder Society 1995;10(3):288-94.
1995: Trottier Y; Devys D; Imbert G; Saudou F; An I; Lutz Y; Weber C; Agid Y; Hirsch E C; Mandel J L
Cellular localization of the Huntington's disease protein and discrimination of the normal and mutated form.
Nature genetics 1995;10(1):104-10.
1995: Sirigu A; Cohen L; Duhamel J R; Pillon B; Dubois B; Agid Y; Pierrot-Deseilligny C
Congruent unilateral impairments for real and imagined hand movements.
Neuroreport 1995;6(7):997-1001.
1995: Pêcheux C; Mouret J F; Dürr A; Agid Y; Feingold J; Brice A; Dodé C; Kaplan J C
Sequence analysis of the CCG polymorphic region adjacent to the CAG triplet repeat of the HD gene in normal and HD chromosomes.
Journal of medical genetics 1995;32(5):399-400.
1995: Blanchard V; Chritin M; Vyas S; Savasta M; Feuerstein C; Agid Y; Javoy-Agid F; Raisman-Vozari R
Long-term induction of tyrosine hydroxylase expression: compensatory response to partial degeneration of the dopaminergic nigrostriatal system in the rat brain.
Journal of neurochemistry 1995;64(4):1669-79.
1995: Michel P P; Agid Y
Death of septal cholinergic neurons produced by chronic exposure to glutamate is prevented by the noncompetitive NMDA receptor/channel antagonist, MK-801: role of nerve growth factor and nitric oxide.
Journal of neuroscience research 1995;40(6):764-75.
1995: Sirigu A; Cohen L; Duhamel J R; Pillon B; Dubois B; Agid Y
A selective impairment of hand posture for object utilization in apraxia.
Cortex; a journal devoted to the study of the nervous system and behavior 1995;31(1):41-55.
1995: Dürr A; Dodé C; Hahn V; Pêcheux C; Pillon B; Feingold J; Kaplan J C; Agid Y; Brice A
Diagnosis of "sporadic" Huntington's disease.
Journal of the neurological sciences 1995;129(1):51-5.
1995: Pillon B; Gouider-Khouja N; Deweer B; Vidailhet M; Malapani C; Dubois B; Agid Y
Neuropsychological pattern of striatonigral degeneration: comparison with Parkinson's disease and progressive supranuclear palsy.
Journal of neurology, neurosurgery, and psychiatry 1995;58(2):174-9.
1995: Ruberg M; Scherman D; Javoy-Agid F; Agid Y
Dopamine denervation, age of onset, and Parkinson's disease.
Neurology 1995;45(2):392.
1995: Anglade P; Tsuji S; Javoy-Agid F; Agid Y; Hirsch E C
Plasticity of nerve afferents to nigrostriatal neurons in Parkinson's disease.
Annals of neurology 1995;37(2):265-72.
1995: Dubourg O; Dürr A; Cancel G; Stevanin G; Chneiweiss H; Penet C; Agid Y; Brice A
Analysis of the SCA1 CAG repeat in a large number of families with dominant ataxia: clinical and molecular correlations.
Annals of neurology 1995;37(2):176-80.
1995: Michel P P; Vyas S; Agid Y
Synergistic differentiation by chronic exposure to cyclic AMP and nerve growth factor renders rat phaeochromocytoma PC12 cells totally dependent upon trophic support for survival.
The European journal of neuroscience 1995;7(2):251-60.
1995: Anglade P; Tsuji S; Agid Y; Hirsch E C
Neuronal plasticity and Parkinson disease.
Molecular and chemical neuropathology / sponsored by the International Society for Neurochemistry and the World Federation of Neurology and research groups on neurochemistry and cerebrospinal fluid 1995;24(2-3):251-5.
1995: Stevanin G; Cancel G; Dürr A; Chneiweiss H; Dubourg O; Weissenbach J; Cann H M; Agid Y; Brice A
The gene for spinal cerebellar ataxia 3 (SCA3) is located in a region of approximately 3 cM on chromosome 14q24.3-q32.2.
American journal of human genetics 1995;56(1):193-201.
1995: Levy R; Ruberg M; Herrero M T; Villares J; Javoy-Agid F; Agid Y; Hirsch E C
Alterations of GABAergic neurons in the basal ganglia of patients with progressive supranuclear palsy: an in situ hybridization study of GAD67 messenger RNA.
Neurology 1995;45(1):127-34.
1995: Fontaine B; Rime C S; Hazan J; Dürr A; Stevanin G; Penet C; Reboul J; Agid Y; Lyon-Caen O; Baumann N
Exclusion of the candidate locus FSP1 in six families with late-onset autosomal dominant spastic paraplegia.
Neuromuscular disorders : NMD 1995;5(1):11-7.
1995: Billette de Villemeur T; Agid Y
[Iatrogenic Creutzfedt-Jacob disease. What precautions are to be taken for the prevention of neurosurgical contamination?]
Neuro-Chirurgie 1995;41(1):1-2.
1995: Dürr A; Brice A; Lepage-Lezin A; Cancel G; Smadja D; Vernant J C; Agid Y
Autosomal dominant cerebellar ataxia type I linked to chromosome 12q (SCA2: spinocerebellar ataxia type 2).
Clinical neuroscience (New York, N.Y.) 1995;3(1):12-6.
1994: Brandel J P; Marconi R; Serdaru M; Vidailhet M; Agid Y
Down's syndrome and Parkinson's disease.
Neurology 1994;44(12):2419-20.
1994: Gouider R; LeGuern E; Emile J; Tardieu S; Cabon F; Samid M; Weissenbach J; Agid Y; Bouche P; Brice A
Hereditary neuralgic amyotrophy and hereditary neuropathy with liability to pressure palsies: two distinct clinical, electrophysiologic, and genetic entities.
Neurology 1994;44(12):2250-2.
1994: Mouatt-Prigent A; Agid Y; Hirsch E C
Does the calcium binding protein calretinin protect dopaminergic neurons against degeneration in Parkinson's disease?
Brain research 1994;668(1-2):62-70.
1994: Stevanin G; Sousa P S; Cancel G; Dürr A; Dubourg O; Nicholson G A; Weissenbach J; Jardim E; Agid Y; Cassa E
The gene for Machado-Joseph disease maps to the same 3-cM interval as the spinal cerebellar ataxia 3 gene on chromosome 14q.
Neurobiology of disease 1994;1(1-2):79-82.
1994: Villares J; Strada O; Faucheux B; Javoy-Agid F; Agid Y; Hirsch E C
Loss of striatal high affinity NGF binding sites in progressive supranuclear palsy but not in Parkinson's disease.
Neuroscience letters 1994;182(1):59-62.
1994: Boissière F; Hunot S; Faucheux B; Mouatt-Prigent A; Agid Y; Hirsch E C
High affinity neurotrophin receptors in cholinergic neurons in the human brain.
Comptes rendus de l'Académie des sciences. Série III, Sciences de la vie 1994;317(11):997-1003.
1994: Lehéricy S; Brandel J P; Hirsch E C; Anglade P; Villares J; Scherman D; Duyckaerts C; Javoy-Agid F; Agid Y
Monoamine vesicular uptake sites in patients with Parkinson's disease and Alzheimer's disease, as measured by tritiated dihydrotetrabenazine autoradiography.
Brain research 1994;659(1-2):1-9.
1994: Sian J; Dexter D T; Lees A J; Daniel S; Agid Y; Javoy-Agid F; Jenner P; Marsden C D
Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia.
Annals of neurology 1994;36(3):348-55.
1994: Vidailhet M; Bonnet A M; Marconi R; Gouider-Khouja N; Agid Y
Do parkinsonian symptoms and levodopa-induced dyskinesias start in the foot?
Neurology 1994;44(9):1613-6.
1994: Le Guern E; Ravise N; Gugenheim M; Vignal A; Penet C; Bouche P; Weissenbach J; Agid Y; Brice A
Linkage analyses between dominant X-linked Charcot-Marie-Tooth disease, and 15 Xq11-Xq21 microsatellites in a new large family: three new markers are closely linked to the gene.
Neuromuscular disorders : NMD 1994;4(5-6):463-9.
1994: Hazan J; Fontaine B; Bruyn R P; Lamy C; van Deutekom J C; Rime C S; Dürr A; Melki J; Lyon-Caen O; Agid Y
Linkage of a new locus for autosomal dominant familial spastic paraplegia to chromosome 2p.
Human molecular genetics 1994;3(9):1569-73.
1994: Kastner A; Anglade P; Bounaix C; Damier P; Javoy-Agid F; Bromet N; Agid Y; Hirsch E C
Immunohistochemical study of catechol-O-methyltransferase in the human mesostriatal system.
Neuroscience 1994;62(2):449-57.
1994: Vyas S; Michel P P; Copin M C; Biguet N F; Thomasset M; Agid Y
Induction of calbindin-D 28K gene and protein expression by physiological stimuli but not in calcium-mediated degeneration in rat PC12 pheochromocytoma cells.
FEBS letters 1994;351(1):53-7.
1994: Belal S; Cancel G; Stevanin G; Hentati F; Khati C; Ben Hamida C; Auburger G; Agid Y; Ben Hamida M; Brice A
Clinical and genetic analysis of a Tunisian family with autosomal dominant cerebellar ataxia type 1 linked to the SCA2 locus.
Neurology 1994;44(8):1423-6.
1994: Kastner A; Herrero M T; Hirsch E C; Guillen J; Luquin M R; Javoy-Agid F; Obeso J A; Agid Y
Decreased tyrosine hydroxylase content in the dopaminergic neurons of MPTP-intoxicated monkeys: effect of levodopa and GM1 ganglioside therapy.
Annals of neurology 1994;36(2):206-14.
1994: Dournaud P; Cervera-Pierot P; Hirsch E; Javoy-Agid F; Kordon C; Agid Y; Epelbaum J
Somatostatin messenger RNA-containing neurons in Alzheimer's disease: an in situ hybridization study in hippocampus, parahippocampal cortex and frontal cortex.
Neuroscience 1994;61(4):755-64.
1994: Dürr A; Brice A; Serdaru M; Rancurel G; Derouesné C; Lyon-Caen O; Agid Y; Fontaine B
The phenotype of "pure" autosomal dominant spastic paraplegia.
Neurology 1994;44(7):1274-7.
1994: Pillon B; Deweer B; Michon A; Malapani C; Agid Y; Dubois B
Are explicit memory disorders of progressive supranuclear palsy related to damage to striatofrontal circuits? Comparison with Alzheimer's, Parkinson's, and Huntington's diseases.
Neurology 1994;44(7):1264-70.
1994: Mazzetti P; Le Guern E; Bonnet A M; Vidailhet M; Brice A; Agid Y
Familial Parkinson's disease and polymorphism at the CYP2D6 locus.
Journal of neurology, neurosurgery, and psychiatry 1994;57(7):871-2.
1994: Michon A; Deweer B; Pillon B; Agid Y; Dubois B
Relation of anosognosia to frontal lobe dysfunction in Alzheimer's disease.
Journal of neurology, neurosurgery, and psychiatry 1994;57(7):805-9.
1994: Zhang P; Anglade P; Hirsch E C; Javoy-Agid F; Agid Y
Distribution of manganese-dependent superoxide dismutase in the human brain.
Neuroscience 1994;61(2):317-30.
1994: Boka G; Anglade P; Wallach D; Javoy-Agid F; Agid Y; Hirsch E C
Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease.
Neuroscience letters 1994;172(1-2):151-4.
1994: Malessa S; Gaymard B; Rivaud S; Cervera P; Hirsch E; Verny M; Duyckaerts C; Agid Y; Pierrot-Deseilligny C
Role of pontine nuclei damage in smooth pursuit impairment of progressive supranuclear palsy: a clinical-pathologic study.
Neurology 1994;44(4):716-21.
1994: Vermersch A I; Rivaud S; Vidailhet M; Bonnet A M; Gaymard B; Agid Y; Pierrot-Deseilligny C
Sequences of memory-guided saccades in Parkinson's disease.
Annals of neurology 1994;35(4):487-90.
1994: Benomar A; Le Guern E; Dürr A; Ouhabi H; Stevanin G; Yahyaoui M; Chkili T; Agid Y; Brice A
Autosomal-dominant cerebellar ataxia with retinal degeneration (ADCA type II) is genetically different from ADCA type I.
Annals of neurology 1994;35(4):439-44.
1994: Vidailhet M; Rivaud S; Gouider-Khouja N; Pillon B; Bonnet A M; Gaymard B; Agid Y; Pierrot-Deseilligny C
Eye movements in parkinsonian syndromes.
Annals of neurology 1994;35(4):420-6.
1994: Holemans S; Javoy-Agid F; Agid Y; De Paermentier F; Laterre E C; Maloteaux J M
Sulfonylurea binding sites in normal human brain and in Parkinson's disease, progressive supranuclear palsy and Huntington's disease.
Brain research 1994;642(1-2):327-33.
1994: Michel P P; Vyas S; Anglade P; Ruberg M; Agid Y
Morphological and molecular characterization of the response of differentiated PC12 cells to calcium stress.
The European journal of neuroscience 1994;6(4):577-86.
1994: Deweer B; Ergis A M; Fossati P; Pillon B; Boller F; Agid Y; Dubois B
Explicit memory, procedural learning and lexical priming in Alzheimer's disease.
Cortex; a journal devoted to the study of the nervous system and behavior 1994;30(1):113-26.
1994: Blanchard V; Raisman-Vozari R; Vyas S; Michel P P; Javoy-Agid F; Uhl G; Agid Y
Differential expression of tyrosine hydroxylase and membrane dopamine transporter genes in subpopulations of dopaminergic neurons of the rat mesencephalon.
Brain research. Molecular brain research 1994;22(1-4):29-38.
1994: Malapani C; Pillon B; Dubois B; Agid Y
Impaired simultaneous cognitive task performance in Parkinson's disease: a dopamine-related dysfunction.
Neurology 1994;44(2):319-26.
1994: Marconi R; Lefebvre-Caparros D; Bonnet A M; Vidailhet M; Dubois B; Agid Y
Levodopa-induced dyskinesias in Parkinson's disease phenomenology and pathophysiology.
Movement disorders : official journal of the Movement Disorder Society 1994;9(1):2-12.
1994: Cancel G; Dürr A; Stevanin G; Chneiweiss H; Duyckaerts C; Serdaru M; de Toffol B; Agid Y; Brice A
Is DRPLA also linked to 14q?
Nature genetics 1994;6(1):8.
1994: Petit H; Agid Y
[Information on the consequences of the discovery of the Huntington disease gene]
Revue neurologique 1994;150(5):338-9.
1993: Dürr A; Chneiweiss H; Khati C; Stevanin G; Cancel G; Feingold J; Agid Y; Brice A
Phenotypic variability in autosomal dominant cerebellar ataxia type I is unrelated to genetic heterogeneity.
Brain : a journal of neurology 1993;116 ( Pt 6)():1497-508.
1993: Strada O; Hirsch E C; Javoy-Agid F; Duyckaerts C; Hauw J J; Agid Y
Low affinity nerve growth factor receptor, adrenal transplant and Parkinson's disease.
Journal of the neurological sciences 1993;120(1):33-7.
1993: Verin M; Partiot A; Pillon B; Malapani C; Agid Y; Dubois B
Delayed response tasks and prefrontal lesions in man--evidence for self generated patterns of behaviour with poor environmental modulation.
Neuropsychologia 1993;31(12):1379-96.
1993: Villares J; Faucheux B; Strada O; Hirsch E C; Agid Y; Javoy-Agid F
Autoradiographic study of [125I]epidermal growth factor-binding sites in the mesencephalon of control and parkinsonian brains post-mortem.
Brain research 1993;628(1-2):72-6.
1993: Dürr A; Stevanin G; Jedynak C P; Penet C; Agid Y; Brice A
Familial essential tremor and idiopathic torsion dystonia are different genetic entities.
Neurology 1993;43(11):2212-4.
1993: Dodé C; Dürr A; Pêcheux C; Mouret J F; Belal S; Bachner L; Agid Y; Kaplan J C; Brice A; Feingold J
Huntington's disease in French families: CAG repeat expansion and linkage disequilibrium analysis.
Comptes rendus de l'Académie des sciences. Série III, Sciences de la vie 1993;316(11):1374-80.
1993: Herrero M T; Kastner A; Perez-Otaño I; Hirsch E C; Luquin M R; Javoy-Agid F; Del Río J; Obeso J A; Agid Y
Gangliosides and parkinsonism.
Neurology 1993;43(10):2132-4.
1993: Herrero M T; Perez-Otaño I; Oset C; Kastner A; Hirsch E C; Agid Y; Luquin M R; Obeso J A; Del Rio J
GM-1 ganglioside promotes the recovery of surviving midbrain dopaminergic neurons in MPTP-treated monkeys.
Neuroscience 1993;56(4):965-72.
1993: Herrero M T; Hirsch E C; Javoy-Agid F; Obeso J A; Agid Y
Differential vulnerability to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine of dopaminergic and cholinergic neurons in the monkey mesopontine tegmentum.
Brain research 1993;624(1-2):281-5.
1993: Herrero M T; Hirsch E C; Kastner A; Ruberg M; Luquin M R; Laguna J; Javoy-Agid F; Obeso J A; Agid Y
Does neuromelanin contribute to the vulnerability of catecholaminergic neurons in monkeys intoxicated with MPTP?
Neuroscience 1993;56(2):499-511.
1993: Stevanin G; Chneiweiss H; Le Guern E; Ravise N; Dürr A; Penet C; Agid Y; Brice A
Genetic heterogeneity of autosomal dominant cerebellar ataxia type I: evidence for the existence of a third locus.
Human molecular genetics 1993;2(9):1483-5.
1993: Cancel G; Khati C; Stevanin G; Pages J C; Agid Y; Brice A; Cann H M
Endothelin 1 is not a candidate gene for spinal cerebellar ataxia 1.
Human molecular genetics 1993;2(9):1477-9.
1993: Kastner A; Hirsch E C; Herrero M T; Javoy-Agid F; Agid Y
Immunocytochemical quantification of tyrosine hydroxylase at a cellular level in the mesencephalon of control subjects and patients with Parkinson's and Alzheimer's disease.
Journal of neurochemistry 1993;61(3):1024-34.
1993: Blanchard V; Raisman-Vozari R; Savasta M; Hirsch E; Javoy-Agid F; Feuerstein C; Agid Y
Cellular quantification of tyrosine hydroxylase in the rat brain by immunoautoradiography.
Journal of neurochemistry 1993;61(2):617-26.
1993: Zhang P; Damier P; Hirsch E C; Agid Y; Ceballos-Picot I; Sinet P M; Nicole A; Laurent M; Javoy-Agid F
Preferential expression of superoxide dismutase messenger RNA in melanized neurons in human mesencephalon.
Neuroscience 1993;55(1):167-75.
1993: Herrero M T; Ruberg M; Hirsch E C; Mouatt A; Tobin A J; Agid Y; Obeso J A; Javoy-Agid F
In situ hybridization of GAD mRNA in monkey and human brain: quantification at both regional and cellular levels.
Neuroscience letters 1993;157(1):57-61.
1993: Anglade P; Tsuji S; Hirsch E C; Javoy-Agid F; Agid Y
Ultrastructural relations between nigrostriatal dopaminergic neurons and cholinergic nerve endings in the human brain.
Histology and histopathology 1993;8(3):501-4.
1993: Blin J; Baron J C; Dubois B; Crouzel C; Fiorelli M; Attar-Lévy D; Pillon B; Fournier D; Vidailhet M; Agid Y
Loss of brain 5-HT2 receptors in Alzheimer's disease. In vivo assessment with positron emission tomography and [18F]setoperone.
Brain : a journal of neurology 1993;116 ( Pt 3)():497-510.
1993: Faucheux B A; Hirsch E C; Villares J; Selimi F; Mouatt-Prigent A; Javoy-Agid F; Hauw J J; Agid Y
Distribution of 125I-ferrotransferrin binding sites in the mesencephalon of control subjects and patients with Parkinson's disease.
Journal of neurochemistry 1993;60(6):2338-41.
1993: Khati C; Stevanin G; Durr A; Chneiweiss H; Belal S; Seck A; Cann H; Brice A; Agid Y
Genetic heterogeneity of autosomal dominant cerebellar ataxia type 1: clinical and genetic analysis of 10 French families.
Neurology 1993;43(6):1131-7.
1993: Anglade P; Hirsch E C; Brandel J P; Javoy-Agid F; Duyckaerts C; Hauw J J; Agid Y
Adrenal transplant, dopaminergic neurons, and Parkinson's disease.
Annals of neurology 1993;33(6):662-3.
1993: Vermersch P; Delacourte A; Javoy-Agid F; Hauw J J; Agid Y
Dementia in Parkinson's disease: biochemical evidence for cortical involvement using the immunodetection of abnormal Tau proteins.
Annals of neurology 1993;33(5):445-50.
1993: Lehéricy S; Hirsch E C; Cervera-Piérot P; Hersh L B; Bakchine S; Piette F; Duyckaerts C; Hauw J J; Javoy-Agid F; Agid Y
Heterogeneity and selectivity of the degeneration of cholinergic neurons in the basal forebrain of patients with Alzheimer's disease.
The Journal of comparative neurology 1993;330(1):15-31.
1993: Pillon B; Deweer B; Agid Y; Dubois B
Explicit memory in Alzheimer's, Huntington's, and Parkinson's diseases.
Archives of neurology 1993;50(4):374-9.
1993: Carter D; Campion D; d'Amato T; Jay M; Brice A; Bellis M; Mallet J; Agid Y
No mutation in codon 713 of the amyloid precursor gene in schizophrenic patients.
Human molecular genetics 1993;2(3):321.
1993: Kastner A; Hirsch E C; Agid Y; Javoy-Agid F
Tyrosine hydroxylase protein and messenger RNA in the dopaminergic nigral neurons of patients with Parkinson's disease.
Brain research 1993;606(2):341-5.
1993: Damier P; Hirsch E C; Zhang P; Agid Y; Javoy-Agid F
Glutathione peroxidase, glial cells and Parkinson's disease.
Neuroscience 1993;52(1):1-6.
1993: Brice A; Boch A L; Stevanin G; Khati C; Dubois B; Agid Y; Campion D; Clerget F; Mallet J; Bellis M
Absence of the amyloid precursor protein gene mutation (APP717: Val->Ile) in 85 cases of early onset Alzheimer's disease.
Journal of neurology, neurosurgery, and psychiatry 1993;56(1):112-3.
1993: Agid Y; Ruberg M; Javoy-Agid F; Hirsch E; Raisman-Vozari R; Vyas S; Faucheux B; Michel P; Kastner A; Blanchard V
Are dopaminergic neurons selectively vulnerable to Parkinson's disease?
Advances in neurology 1993;60():148-64.
1993: Agid Y
[Mechanism of cell death in neurodegenerative disorders: apropos of Parkinson disease]
Comptes rendus des séances de la Société de biologie et de ses filiales 1993;187(1):37-46.
1993: Herrero M T; Hirsch E C; Kastner A; Luquin M R; Javoy-Agid F; Gonzalo L M; Obeso J A; Agid Y
Neuromelanin accumulation with age in catecholaminergic neurons from Macaca fascicularis brainstem.
Developmental neuroscience 1993;15(1):37-48.
1992: Strada O; Hirsch E C; Javoy-Agid F; Lehéricy S; Ruberg M; Hauw J J; Agid Y
Does loss of nerve growth factor receptors precede loss of cholinergic neurons in Alzheimer's disease? An autoradiographic study in the human striatum and basal forebrain.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1992;12(12):4766-74.
1992: Michel P P; Agid Y
The glutamate antagonist, MK-801, does not prevent dopaminergic cell death induced by the 1-methyl-4-phenylpyridinium ion (MPP+) in rat dissociated mesencephalic cultures.
Brain research 1992;597(2):233-40.
1992: Carter D A; Desmarais E; Bellis M; Campion D; Clerget-Darpoux F; Brice A; Agid Y; Jaillard-Serradt A; Mallet J
More missense in amyloid gene.
Nature genetics 1992;2(4):255-6.
1992: Marconi R; Bonnet A M; Vidailhet M; Agid Y
The IMAO-B MDL 72.974 A in Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 1992;55(11):1096-7.
1992: Brice A; Ravisé N; Stevanin G; Gugenheim M; Bouche P; Penet C; Agid Y
Duplication within chromosome 17p11.2 in 12 families of French ancestry with Charcot-Marie-Tooth disease type 1a. The French CMT Research Group.
Journal of medical genetics 1992;29(11):807-12.
1992: Blin J; Vidailhet M J; Pillon B; Dubois B; Feve J R; Agid Y
Corticobasal degeneration: decreased and asymmetrical glucose consumption as studied with PET.
Movement disorders : official journal of the Movement Disorder Society 1992;7(4):348-54.
1992: Strada O; Vyas S; Hirsch E C; Ruberg M; Brice A; Agid Y; Javoy-Agid F
Decreased choline acetyltransferase mRNA expression in the nucleus basalis of Meynert in Alzheimer disease: an in situ hybridization study.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(20):9549-53.
1992: Morvan D; Komajda M; Doan L D; Brice A; Isnard R; Seck A; Lechat P; Agid Y; Grosgogeat Y
Cardiomyopathy in Friedreich's ataxia: a Doppler-echocardiographic study.
European heart journal 1992;13(10):1393-8.
1992: Kastner A; Hirsch E C; Lejeune O; Javoy-Agid F; Rascol O; Agid Y
Is the vulnerability of neurons in the substantia nigra of patients with Parkinson's disease related to their neuromelanin content?
Journal of neurochemistry 1992;59(3):1080-9.
1992: Chabriat H; Levasseur M; Vidailhet M; Loc'h C; Mazière B; Bourguignon M H; Bonnet A M; Zilbovicius M; Raynaud C; Agid Y
In-vivo SPECT imaging of D2 receptor with iodine-iodolisuride: results in supranuclear palsy.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1992;33(8):1481-5.
1992: Michel P P; Vyas S; Agid Y
Toxic effects of iron for cultured mesencephalic dopaminergic neurons derived from rat embryonic brains.
Journal of neurochemistry 1992;59(1):118-27.
1992: Hirsch E C; Mouatt A; Faucheux B; Bonnet A M; Javoy-Agid F; Graybiel A M; Agid Y
Dopamine, tremor, and Parkinson's disease.
Lancet 1992;340(8811):125-6.
1992: Lange K W; Javoy-Agid F; Agid Y; Jenner P; Marsden C D
Brain muscarinic cholinergic receptors in Huntington's disease.
Journal of neurology 1992;239(2):103-4.
1992: Dubois B; Pillon B; Agid Y
Deterioration of dopaminergic pathways and alterations in cognition and motor functions.
Journal of neurology 1992;239 Suppl 1():S9-12.
1992: Emre M; Rinne U K; Rascol A; Lees A; Agid Y; Lataste X
Effects of a selective partial D1 agonist, CY 208-243, in de novo patients with Parkinson disease.
Movement disorders : official journal of the Movement Disorder Society 1992;7(3):239-43.
1992: Ransmayr G; Cervera P; Hirsch E C; Berger W; Fischer W; Agid Y
Alzheimer's disease: is the decrease of the cholinergic innervation of the hippocampus related to intrinsic hippocampal pathology?
Neuroscience 1992;47(4):843-51.
1991: Holemans S; Javoy F; Agid Y; Laterre E C; Maloteaux J M
[3H]MK-801 binding to NMDA glutamatergic receptors in Parkinson's disease and progressive supranuclear palsy.
Brain research 1991;565(1):154-7.
1991: Malessa S; Hirsch E C; Cervera P; Javoy-Agid F; Duyckaerts C; Hauw J J; Agid Y
Progressive supranuclear palsy: loss of choline-acetyltransferase-like immunoreactive neurons in the pontine reticular formation.
Neurology 1991;41(10):1593-7.
1991: Raisman-Vozari R; Hirsch E; Javoy-Agid F; Vassort C; Savasta M; Feuerstein C; Thibault J; Agid Y
Quantitative autoradiography of tyrosine hydroxylase immunoreactivity in the rat brain.
Journal of neurochemistry 1991;57(4):1212-22.
1991: Blin J; Dubois B; Bonnet A M; Vidailhet M; Brandabur M; Agid Y
Does ageing aggravate parkinsonian disability?
Journal of neurology, neurosurgery, and psychiatry 1991;54(9):780-2.
1991: Dexter D T; Carayon A; Javoy-Agid F; Agid Y; Wells F R; Daniel S E; Lees A J; Jenner P; Marsden C D
Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia.
Brain : a journal of neurology 1991;114 ( Pt 4)():1953-75.
1991: Pierrot-Deseilligny C; Rivaud S; Gaymard B; Agid Y
Cortical control of reflexive visually-guided saccades.
Brain : a journal of neurology 1991;114 ( Pt 3)():1473-85.
1991: Agid Y
Parkinson's disease: pathophysiology.
Lancet 1991;337(8753):1321-4.
1991: Pillon B; Dubois B; Ploska A; Agid Y
Severity and specificity of cognitive impairment in Alzheimer's, Huntington's, and Parkinson's diseases and progressive supranuclear palsy.
Neurology 1991;41(5):634-43.
1991: Hirsch E C; Brandel J P; Galle P; Javoy-Agid F; Agid Y
Iron and aluminum increase in the substantia nigra of patients with Parkinson's disease: an X-ray microanalysis.
Journal of neurochemistry 1991;56(2):446-51.
1991: Lehéricy S; Hirsch E C; Hersh L B; Agid Y
Cholinergic neuronal loss in the globus pallidus of Alzheimer disease patients.
Neuroscience letters 1991;123(2):152-5.
1991: Juncos J L; Hirsch E C; Malessa S; Duyckaerts C; Hersh L B; Agid Y
Mesencephalic cholinergic nuclei in progressive supranuclear palsy.
Neurology 1991;41(1):25-30.
1991: Ceballos I; Javoy-Agid F; Delacourte A; Defossez A; Lafon M; Hirsch E; Nicole A; Sinet P M; Agid Y
Neuronal localization of copper-zinc superoxide dismutase protein and mRNA within the human hippocampus from control and Alzheimer's disease brains.
Free radical research communications 1991;12-13 Pt 2():571-80.
1991: Brandel J P; Hirsch E C; Malessa S; Duyckaerts C; Cervera P; Agid Y
Differential vulnerability of cholinergic projections to the mediodorsal nucleus of the thalamus in senile dementia of Alzheimer type and progressive supranuclear palsy.
Neuroscience 1991;41(1):25-31.
1991: Pierrot-Deseilligny C; Rivaud S; Gaymard B; Agid Y
Cortical control of memory-guided saccades in man.
Experimental brain research. Experimentelle Hirnforschung. Expérimentation cérébrale 1991;83(3):607-17.
1991: Jedynak C P; Bonnet A M; Agid Y
Tremor and idiopathic dystonia.
Movement disorders : official journal of the Movement Disorder Society 1991;6(3):230-6.
1991: Pillon B; Dubois B; Agid Y
Severity and specificity of cognitive impairment in Alzheimer's, Huntington's, and Parkinson's diseases and progressive supranuclear palsy.
Annals of the New York Academy of Sciences 1991;640():224-7.
1990: Chavoix C; Samson Y; Pappata S; Prenant C; Mazière M; Seck A; Agid Y
Positron emission tomography study of brain benzodiazepine receptors in Friedreich's ataxia.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1990;17(4):404-9.
1990: Malessa S; Hirsch E C; Cervera P; Duyckaerts C; Agid Y
Catecholaminergic systems in the medulla oblongata in parkinsonian syndromes: a quantitative immunohistochemical study in Parkinson's disease, progressive supranuclear palsy, and striatonigral degeneration.
Neurology 1990;40(11):1739-43.
1990: Mann V M; Cooper J M; Javoy-Agid F; Agid Y; Jenner P; Schapira A H
Mitochondrial function and parental sex effect in Huntington's disease.
Lancet 1990;336(8717):749.
1990: Dubois B; Pilon B; Lhermitte F; Agid Y
Cholinergic deficiency and frontal dysfunction in Parkinson's disease.
Annals of neurology 1990;28(2):117-21.
1990: Vidailhet M J; Bonnet A M; Belal S; Dubois B; Marle C; Agid Y
Ropinirole without levodopa in Parkinson's disease.
Lancet 1990;336(8710):316-7.
1990: Blin J; Baron J C; Dubois B; Pillon B; Cambon H; Cambier J; Agid Y
Positron emission tomography study in progressive supranuclear palsy. Brain hypometabolic pattern and clinicometabolic correlations.
Archives of neurology 1990;47(7):747-52.
1990: Dexter D T; Carayon A; Vidailhet M; Ruberg M; Agid F; Agid Y; Lees A J; Wells F R; Jenner P; Marsden C D
Decreased ferritin levels in brain in Parkinson's disease.
Journal of neurochemistry 1990;55(1):16-20.
1990: Cedarbaum J M; Sheu K F; Harding B J; Blass J P; Javoy-Agid F; Agid Y
Deficiency of glutamate dehydrogenase in postmortem brain samples from parkinsonian putamen.
Annals of neurology 1990;28(1):111-2.
1990: Hirsch E C; Duyckaerts C; Javoy-Agid F; Hauw J J; Agid Y
Does adrenal graft enhance recovery of dopaminergic neurons in Parkinson's disease?
Annals of neurology 1990;27(6):676-82.
1990: Hanauer A; Fujita R; Trouillas P; Tommasi-Davenas C; Agid Y; Seck A; Mandel J L
Prenatal diagnosis of Friedreich ataxia.
Lancet 1990;335(8697):1102.
1990: Dumas S; Javoy-Agid F; Hirsch E; Agid Y; Mallet J
Tyrosine hydroxylase gene expression in human ventral mesencephalon: detection of tyrosine hydroxylase messenger RNA in neurites.
Journal of neuroscience research 1990;25(4):569-75.
1990: Ceballos I; Lafon M; Javoy-Agid F; Hirsch E; Nicole A; Sinet P M; Agid Y
Superoxide dismutase and Parkinson's disease.
Lancet 1990;335(8696):1035-6.
1990: Cervera P; Duyckaerts C; Ruberg M; Hirsch E; Ransmayr G; Hauw J J; Agid Y
Tyrosine hydroxylase-like immunoreactivity in senile plaques is not related to the density of tyrosine hydroxylase-positive fibers in patients with Alzheimer's disease.
Neuroscience letters 1990;110(1-2):210-5.
1990: Dubois B; Pillon B; Sternic N; Lhermitte F; Agid Y
Age-induced cognitive disturbances in Parkinson's disease.
Neurology 1990;40(1):38-41.
1990: Raisman-Vozari R; Girault J A; Moussaoui S; Feuerstein C; Jenner P; Marsden C D; Agid Y
Lack of change in striatal DARPP-32 levels following nigrostriatal dopaminergic lesions in animals and in parkinsonian syndromes in man.
Brain research 1990;507(1):45-50.
1990: Agid Y
[From posture to initiation of movement]
Revue neurologique 1990;146(10):536-42.
1990: Ruberg M; Mayo W; Brice A; Duyckaerts C; Hauw J J; Simon H; LeMoal M; Agid Y
Choline acetyltransferase activity and [3H]vesamicol binding in the temporal cortex of patients with Alzheimer's disease, Parkinson's disease, and rats with basal forebrain lesions.
Neuroscience 1990;35(2):327-33.
1990: Thibaut F; Hirsch E C; Raisman R; Javoy-Agid F; Agid Y
Microtopography of D1 dopaminergic binding sites in the human substantia nigra: an autoradiographic study.
Neuroscience 1990;37(2):387-98.
1990: Javoy-Agid F; Hirsch E C; Dumas S; Duyckaerts C; Mallet J; Agid Y
Decreased tyrosine hydroxylase messenger RNA in the surviving dopamine neurons of the substantia nigra in Parkinson's disease: an in situ hybridization study.
Neuroscience 1990;38(1):245-53.
1990: Agid Y; Graybiel A M; Ruberg M; Hirsch E; Blin J; Dubois B; Javoy-Agid F
The efficacy of levodopa treatment declines in the course of Parkinson's disease: do nondopaminergic lesions play a role?
Advances in neurology 1990;53():83-100.
1990: Graybiel A M; Hirsch E C; Agid Y
The nigrostriatal system in Parkinson's disease.
Advances in neurology 1990;53():17-29.
1989: Lehéricy S; Hirsch E C; Cervera P; Hersh L B; Hauw J J; Ruberg M; Agid Y
Selective loss of cholinergic neurons in the ventral striatum of patients with Alzheimer disease.
Proceedings of the National Academy of Sciences of the United States of America 1989;86(21):8580-4.
1989: Vidailhet M; Serdaru M; Agid Y
Singing in the brain: a new form of complex partial seizure?
Journal of neurology, neurosurgery, and psychiatry 1989;52(11):1306.
1989: Blin J; Baron J C; Cambon H; Bonnet A M; Dubois B; Loc'h C; Mazière B; Agid Y
Striatal dopamine D2 receptors in tardive dyskinesia: PET study.
Journal of neurology, neurosurgery, and psychiatry 1989;52(11):1248-52.
1989: Scherman D; Desnos C; Darchen F; Pollak P; Javoy-Agid F; Agid Y
Striatal dopamine deficiency in Parkinson's disease: role of aging.
Annals of neurology 1989;26(4):551-7.
1989: Ceballos I; Javoy-Agid F; Hirsch E C; Dumas S; Kamoun P P; Sinet P M; Agid Y
Localization of copper-zinc superoxide dismutase mRNA in human hippocampus by in situ hybridization.
Neuroscience letters 1989;105(1-2):41-6.
1989: Pillon B; Dubois B; Bonnet A M; Esteguy M; Guimaraes J; Vigouret J M; Lhermitte F; Agid Y
Cognitive slowing in Parkinson's disease fails to respond to levodopa treatment: the 15-objects test.
Neurology 1989;39(6):762-8.
1989: Dexter D T; Wells F R; Lees A J; Agid F; Agid Y; Jenner P; Marsden C D
Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease.
Journal of neurochemistry 1989;52(6):1830-6.
1989: Juncos J L; Engber T M; Raisman R; Susel Z; Thibaut F; Ploska A; Agid Y; Chase T N
Continuous and intermittent levodopa differentially affect basal ganglia function.
Annals of neurology 1989;25(5):473-8.
1989: Pierrot-Deseilligny C; Turell E; Penet C; Lebrigand D; Pillon B; Chain F; Agid Y
Increased wave P 300 latency in progressive supranuclear palsy.
Journal of neurology, neurosurgery, and psychiatry 1989;52(5):656-8.
1989: Girault J A; Raisman-Vozari R; Agid Y; Greengard P
Striatal phosphoproteins in Parkinson disease and progressive supranuclear palsy.
Proceedings of the National Academy of Sciences of the United States of America 1989;86(7):2493-7.
1989: Pierrot-Deseilligny C; Rivaud S; Pillon B; Fournier E; Agid Y
Lateral visually-guided saccades in progressive supranuclear palsy.
Brain : a journal of neurology 1989;112 ( Pt 2)():471-87.
1989: Agid Y
[Parkinson's disease: some physiopathologic aspects and clinical practice]
La Revue du praticien 1989;39(8):641-6.
1989: Dexter D T; Carter C J; Wells F R; Javoy-Agid F; Agid Y; Lees A; Jenner P; Marsden C D
Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease.
Journal of neurochemistry 1989;52(2):381-9.
1989: Pillon B; Dubois B; Cusimano G; Bonnet A M; Lhermitte F; Agid Y
Does cognitive impairment in Parkinson's disease result from non-dopaminergic lesions?
Journal of neurology, neurosurgery, and psychiatry 1989;52(2):201-6.
1989: Fujita R; Agid Y; Trouillas P; Seck A; Tommasi-Davenas C; Driesel A J; Olek K; Grzeschik K H; Nakamura Y; Mandel J L; Hanauer A
Confirmation of linkage of Friedreich ataxia to chromosome 9 and identification of a new closely linked marker.
Genomics 1989;4(1):110-1.
1989: Hirsch E C; Graybiel A M; Hersh L B; Duyckaerts C; Agid Y
Striosomes and extrastriosomal matrix contain different amounts of immunoreactive choline acetyltransferase in the human striatum.
Neuroscience letters 1989;96(2):145-50.
1989: Pourcher E; Bonnet A M; Kefalos J; Dubois B; Agid Y
Effects of etybenzatropine and diazepam on levodopa-induced diphasic dyskinesias in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1989;4(3):195-201.
1989: Vignon J; Chaudieu I; Allaoua H; Journod L; Javoy-Agid F; Agid Y; Chicheportiche R
Comparison of [3H] phencyclidine ([3H] PCP) and [3H] N-[1-(2-thienyl) cyclohexyl] piperidine ([3H] TCP) binding properties to rat and human brain membranes.
Life sciences 1989;45(26):2547-55.
1989: Ransmayr G; Cervera P; Hirsch E; Ruberg M; Hersh L B; Duyckaerts C; Hauw J J; Delumeau C; Agid Y
Choline acetyltransferase-like immunoreactivity in the hippocampal formation of control subjects and patients with Alzheimer's disease.
Neuroscience 1989;32(3):701-14.
1989: Hirsch E C; Graybiel A M; Agid Y
Selective vulnerability of pigmented dopaminergic neurons in Parkinson's disease.
Acta neurologica Scandinavica. Supplementum 1989;126():19-22.
1989: Temlett J A; Quinn N P; Jenner P G; Marsden C D; Pourcher E; Bonnet A M; Agid Y; Markstein R; Lataste X
Antiparkinsonian activity of CY 208-243, a partial D-1 dopamine receptor agonist, in MPTP-treated marmosets and patients with Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1989;4(3):261-5.
1989: Agid Y; Cervera P; Hirsch E; Javoy-Agid F; Lehericy S; Raisman R; Ruberg M
Biochemistry of Parkinson's disease 28 years later: a critical review.
Movement disorders : official journal of the Movement Disorder Society 1989;4 Suppl 1():S126-44.
1989: Epelbaum J; Agid F; Agid Y; Beaudet A; Bertrand P; Enjalbert A; Heidet V; Kordon C; Krantic S; Léonard J F
Somatostatin receptors in brain and pituitary.
Hormone research 1989;31(1-2):45-50.
1989: Javoy-Agid F; Scatton B; Ruberg M; L'Heureux R; Cervera P; Raisman R; Maloteaux J M; Beck H; Agid Y
Distribution of monoaminergic, cholinergic, and GABAergic markers in the human cerebral cortex.
Neuroscience 1989;29(2):251-9.
1988: Taquet H; Javoy-Agid F; Mauborgne A; Benoliel J J; Agid Y; Legrand J C; Tramu G; Cesselin F; Hamon M
Biochemical mapping of cholecystokinin-, substance P-, [Met]enkephalin-, [Leu]enkephalin- and dynorphin A (1-8)-like immunoreactivities in the human cerebral cortex.
Neuroscience 1988;27(3):871-83.
1988: Maloteaux J M; Vanisberg M A; Laterre C; Javoy-Agid F; Agid Y; Laduron P M
[3H]GBR 12935 binding to dopamine uptake sites: subcellular localization and reduction in Parkinson's disease and progressive supranuclear palsy.
European journal of pharmacology 1988;156(3):331-40.
1988: Dubois B; Pillon B; Legault F; Agid Y; Lhermitte F
Slowing of cognitive processing in progressive supranuclear palsy. A comparison with Parkinson's disease.
Archives of neurology 1988;45(11):1194-9.
1988: Epelbaum J; Javoy-Agid F; Enjalbert A; Krantic S; Kordon C; Agid Y
Somatostatin concentrations and binding sites in human frontal cortex are differentially affected in Parkinson's disease associated dementia and in progressive supranuclear palsy.
Journal of the neurological sciences 1988;87(2-3):167-74.
1988: Taquet H; Nomoto M; Rose S; Jenner P; Javoy-Agid F; Mauborgne A; Benoliel J J; Marsden C D; Legrand J C; Agid Y
Levels of Met-enkephalin, Leu-enkephalin, substance P and cholecystokinin in the brain of the common marmoset following long term 1-methyl-4-phenyl-1,2,3,6,-tetrahydropyridine treatment.
Neuropeptides 1988;12(3):105-10.
1988: Blin J; Bonnet A M; Agid Y
Does levodopa aggravate Parkinson's disease?
Neurology 1988;38(9):1410-6.
1988: Pierot L; Desnos C; Blin J; Raisman R; Scherman D; Javoy-Agid F; Ruberg M; Agid Y
D1 and D2-type dopamine receptors in patients with Parkinson's disease and progressive supranuclear palsy.
Journal of the neurological sciences 1988;86(2-3):291-306.
1988: Jégou S; Javoy-Agid F; Delbende C; Tranchand-Bunel D; Coy D H; Agid Y; Vaudry H
Regional distribution of vasoactive intestinal peptide in brains from normal and parkinsonian subjects.
Peptides 1988;9(4):787-93.
1988: Hirsch E; Graybiel A M; Agid Y A
Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease.
Nature 1988;334(6180):345-8.
1988: Agid Y; Pertuiset B; Dubois B
Motoneuron disease as manifestation of lupin seed toxicity.
Lancet 1988;1(8598):1347.
1988: Scherman D; Raisman R; Ploska A; Agid Y
[3H]dihydrotetrabenazine, a new in vitro monoaminergic probe for human brain.
Journal of neurochemistry 1988;50(4):1131-6.
1988: Maloteaux J M; Luabeya M A; Vanisberg M A; Laterre E C; Laduron P M; Javoy-Agid F; Agid Y
Benzodiazepine receptors in normal human brain, in Parkinson's disease and in progressive supranuclear palsy.
Brain research 1988;446(2):321-32.
1988: Hirsch E; Ruberg M; Portier M M; Dardenne M; Agid Y
Characterization of two antigens in parkinsonian Lewy bodies.
Brain research 1988;441(1-2):139-44.
1988: Ruberg M; Villageois A; Bonnet A M; Rieger F; Agid Y; Fahn S
Acetylcholinesterase and butyrylcholinesterase in cerebrospinal fluid from patients with dystonia.
Advances in neurology 1988;50():211-3.
1988: Maloteaux J M; Laterre E C; Laduron P M; Javoy-Agid F; Agid Y
Decrease of serotonin-S2 receptors in temporal cortex of patients with Parkinson's disease and progressive supranuclear palsy.
Movement disorders : official journal of the Movement Disorder Society 1988;3(3):255-62.
1987: Epelbaum J; Javoy-Agid F; Hirsch E; Hauw J J; Kordon C; Krantic S; Agid Y
Brain somatostatin concentrations do not decrease in progressive supranuclear palsy.
Journal of neurology, neurosurgery, and psychiatry 1987;50(11):1526-8.
1987: Dexter D T; Wells F R; Agid F; Agid Y; Lees A J; Jenner P; Marsden C D
Increased nigral iron content in postmortem parkinsonian brain.
Lancet 1987;2(8569):1219-20.
1987: Cash R; Raisman R; Ploska A; Agid Y
Dopamine D-1 receptor and cyclic AMP-dependent phosphorylation in Parkinson's disease.
Journal of neurochemistry 1987;49(4):1075-83.
1987: Bonnet A M; Loria Y; Saint-Hilaire M H; Lhermitte F; Agid Y
Does long-term aggravation of Parkinson's disease result from nondopaminergic lesions?
Neurology 1987;37(9):1539-42.
1987: Dubois B; Danzé F; Pillon B; Cusimano G; Lhermitte F; Agid Y
Cholinergic-dependent cognitive deficits in Parkinson's disease.
Annals of neurology 1987;22(1):26-30.
1987: Delay-Goyet P; Zajac J M; Javoy-Agid F; Agid Y; Roques B P
Regional distribution of mu, delta and kappa opioid receptors in human brains from controls and parkinsonian subjects.
Brain research 1987;414(1):8-14.
1987: Ruberg M; Villageois A; Bonnet A M; Pillon B; Rieger F; Agid Y
Acetylcholinesterase and butyrylcholinesterase activity in the cerebrospinal fluid of patients with neurodegenerative diseases involving cholinergic systems.
Journal of neurology, neurosurgery, and psychiatry 1987;50(5):538-43.
1987: Taquet H; Javoy-Agid F; Mauborgne A; Benoliel J J; Agid Y; Legrand J C; Hamon M; Cesselin F
Brain neuropeptides in progressive supranuclear palsy.
Brain research 1987;411(1):178-82.
1987: Graybiel A M; Hirsch E C; Agid Y A
Differences in tyrosine hydroxylase-like immunoreactivity characterize the mesostriatal innervation of striosomes and extrastriosomal matrix at maturity.
Proceedings of the National Academy of Sciences of the United States of America 1987;84(1):303-7.
1987: Agid Y; Blin J
Nerve cell death in degenerative diseases of the central nervous system: clinical aspects.
Ciba Foundation symposium 1987;126():3-29.
1987: Koller W; O'Hara R; Weiner W; Lang A; Nutt J; Agid Y; Bonnet A M; Jankovic J
Relationship of aging to Parkinson's disease.
Advances in neurology 1987;45():317-21.
1987: Bonnet A M; Tell G; Schechter P J; Grove J; Saint-Hilaire M H; De Smet Y; Agid Y
Cerebrospinal fluid GABA and homocarnosine concentrations in patients with Friedreich's ataxia, Parkinson's disease, and Huntington's chorea.
Movement disorders : official journal of the Movement Disorder Society 1987;2(2):117-23.
1987: Cash R; Raisman R; Cervera P; Javoy-Agid F; Agid Y
Pitfalls in membrane binding sites studies in post-mortem human brain.
Journal of receptor research 1987;7(1-4):527-54.
1987: Agid Y; Javoy-Agid F; Ruberg M; Pillon B; Dubois B; Duyckaerts C; Hauw J J; Baron J C; Scatton B
Progressive supranuclear palsy: anatomoclinical and biochemical considerations.
Advances in neurology 1987;45():191-206.
1986: Sarrieau A; Dussaillant M; Agid F; Philibert D; Agid Y; Rostene W
Autoradiographic localization of glucocorticosteroid and progesterone binding sites in the human post-mortem brain.
Journal of steroid biochemistry 1986;25(5B):717-21.
1986: Bonnet A M; Esteguy M; Tell G; Schechter P J; Hardenberg J; Agid Y
A controlled study of oral vigabatrin (gamma-vinyl GABA) in patients with cerebellar ataxia.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1986;13(4):331-3.
1986: Jenner P; Taquet H; Mauborgne A; Benoliel J T; Cesselin F; Rose S; Javoy-Agid F; Agid Y; Marsden C D
Lack of change in basal ganglia neuropeptide content following subacute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment of the common marmoset.
Journal of neurochemistry 1986;47(5):1548-51.
1986: Pillon B; Dubois B; Lhermitte F; Agid Y
Heterogeneity of cognitive impairment in progressive supranuclear palsy, Parkinson's disease, and Alzheimer's disease.
Neurology 1986;36(9):1179-85.
1986: Dexter D; Carter C; Agid F; Agid Y; Lees A J; Jenner P; Marsden C D
Lipid peroxidation as cause of nigral cell death in Parkinson's disease.
Lancet 1986;2(8507):639-40.
1986: Dubois B; Pillon B; De Saxce H; Lhermitte F; Agid Y
Disappearance of parkinsonian signs after spontaneous vascular 'thalamotomy'.
Archives of neurology 1986;43(8):815-7.
1986: Baron J C; Mazière B; Loc'h C; Cambon H; Sgouropoulos P; Bonnet A M; Agid Y
Loss of striatal [76Br]bromospiperone binding sites demonstrated by positron tomography in progressive supranuclear palsy.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 1986;6(2):131-6.
1986: Cash R; Raisman R; Lanfumey L; Ploska A; Agid Y
Cellular localization of adrenergic receptors in rat and human brain.
Brain research 1986;370(1):127-35.
1986: Raisman R; Cash R; Agid Y
Parkinson's disease: decreased density of 3H-imipramine and 3H-paroxetine binding sites in putamen.
Neurology 1986;36(4):556-60.
1986: Dubois B; Agid Y
[Dopaminergic agonists in Parkinson disease]
La Revue du praticien 1986;36(5):207-14.
1986: Ruberg M; Rieger F; Villageois A; Bonnet A M; Agid Y
Acetylcholinesterase and butyrylcholinesterase in frontal cortex and cerebrospinal fluid of demented and non-demented patients with Parkinson's disease.
Brain research 1986;362(1):83-91.
1986: Agid Y; Ruberg M; Dubois B; Pillon B; Cusimano G; Raisman R; Cash R; Lhermitte F; Javoy-Agid F
Parkinson's disease and dementia.
Clinical neuropharmacology 1986;9 Suppl 2():S22-36.
1986: Agid Y; Taquet H; Cesselin F; Epelbaum J; Javoy-Agid F
Neuropeptides and Parkinson's disease.
Progress in brain research 1986;66():107-16.
1985: Sarrieau A; Javoy-Agid F; Kitabgi P; Dussaillant M; Vial M; Vincent J P; Agid Y; Rostène W H
Characterization and autoradiographic distribution of neurotensin binding sites in the human brain.
Brain research 1985;348(2):375-80.
1985: Cash R; Raisman R; Ploska A; Agid Y
High and low affinity [3H]imipramine binding sites in control and parkinsonian brains.
European journal of pharmacology 1985;117(1):71-80.
1985: Hirsch E; Ruberg M; Dardenne M; Portier M M; Javoy-Agid F; Bach J F; Agid Y
Monoclonal antibodies raised against Lewy bodies in brains from subjects with Parkinson's disease.
Brain research 1985;345(2):374-8.
1985: D'Antona R; Baron J C; Samson Y; Serdaru M; Viader F; Agid Y; Cambier J
Subcortical dementia. Frontal cortex hypometabolism detected by positron tomography in patients with progressive supranuclear palsy.
Brain : a journal of neurology 1985;108 ( Pt 3)():785-99.
1985: Jegou S; Javoy-Agid F; Delbende C; Ruberg M; Vaudry H; Agid Y
Cortical vasoactive intestinal peptide in relation to dementia in Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 1985;48(8):842-3.
1985: Cash R; Lasbennes F; Sercombe R; Seylaz J; Agid Y
Adrenergic receptors on cerebral microvessels in control and parkinsonian subjects.
Life sciences 1985;37(6):531-6.
1985: Taquet H; Javoy-Agid F; Giraud P; Legrand J C; Agid Y; Cesselin F
Dynorphin levels in parkinsonian patients: Leu5-enkephalin production from either proenkephalin A or prodynorphin in human brain.
Brain research 1985;341(2):390-2.
1985: Dubois B; Mayo W; Agid Y; Le Moal M; Simon H
Profound disturbances of spontaneous and learned behaviors following lesions of the nucleus basalis magnocellularis in the rat.
Brain research 1985;338(2):249-58.
1985: Raisman R; Cash R; Ruberg M; Javoy-Agid F; Agid Y
Binding of [3H]SCH 23390 to D-1 receptors in the putamen of control and parkinsonian subjects.
European journal of pharmacology 1985;113(3):467-8.
1985: Monfort J C; Javoy-Agid F; Hauw J J; Dubois B; Agid Y
Brain glutamate decarboxylase in Parkinson's disease with particular reference to a premortem severity index.
Brain : a journal of neurology 1985;108 ( Pt 2)():301-13.
1985: Allen J M; Cross A J; Crow T J; Javoy-Agid F; Agid Y; Bloom S R
Dissociation of neuropeptide Y and somatostatin in Parkinson's disease.
Brain research 1985;337(1):197-200.
1985: Baron J C; Maziere B; Loc'h C; Sgouropoulos P; Bonnet A M; Agid Y
Progressive supranuclear palsy: loss of striatal dopamine receptors demonstrated in vivo by positron tomography.
Lancet 1985;1(8438):1163-4.
1985: Bissette G; Nemeroff C B; Decker M W; Kizer J S; Agid Y; Javoy-Agid F
Alterations in regional brain concentrations of neurotensin and bombesin in Parkinson's disease.
Annals of neurology 1985;17(4):324-8.
1985: Pique L; Jegou S; Bertagna X; Javoy-Agid F; Seurin D; Proeschel M F; Girard F; Agid Y; Vaudry H; Luton J P
Pro-opiomelanocortin peptides in the human hypothalamus: comparative study between normal subjects and Parkinson patients.
Neuroscience letters 1985;54(2-3):141-6.
1985: Cash R; Raisman R; Ruberg M; Agid Y
Adrenergic receptors in frontal cortex in human brain.
European journal of pharmacology 1985;108(3):225-32.
1985: Baron J C; Comar D; Zarifian E; Agid Y; Crouzel C; Loo H; Deniker P; Kellershohn C
Dopaminergic receptor sites in human brain: positron emission tomography.
Neurology 1985;35(1):16-24.
1985: Esteguy M; Bonnet A M; Kefalos J; Lhermitte F; Agid Y
[The L-dopa test in Parkinson's disease]
Revue neurologique 1985;141(5):413-5.
1985: Dubois B; Hauw J J; Ruberg M; Serdaru M; Javoy-Agid F; Agid Y
[Dementia and Parkinson's disease: biochemical and anatomo-clinical correlation]
Revue neurologique 1985;141(3):184-93.
1985: Agid Y; Bonnet A M; Ruberg M; Javoy-Agid F
Pathophysiology of L-dopa-induced abnormal involuntary movements.
Psychopharmacology. Supplementum 1985;2():145-59.
1985: Baron J C; Samson Y; Comar D; Crouzel C; Deniker P; Agid Y
[In vivo study of central serotoninergic receptors in man using positron tomography]
Revue neurologique 1985;141(8-9):537-45.
1985: Epelbaum J; Agid Y; Enjalbert A; Hamon M; Javoy-Agid F; Kordon C; Lamour Y; Moyse E
Somatostatin alterations and brain diseases.
Advances in experimental medicine and biology 1985;188():261-74.
1984: Cash R; Ruberg M; Raisman R; Agid Y
Adrenergic receptors in Parkinson's disease.
Brain research 1984;322(2):269-75.
1984: Llorens-Cortes C; Javoy-Agid F; Agid Y; Taquet H; Schwartz J C
Enkephalinergic markers in substantia nigra and caudate nucleus from Parkinsonian subjects.
Journal of neurochemistry 1984;43(3):874-7.
1984: Bonnet A M; Esteguy M; Guimaraes J; Lhermitte F; Agid Y
Low-dose CU 32-085 (mesulergine) in previously untreated Parkinson's disease.
Neurology 1984;34(8):1127-8.
1984: Rougemont D; Baron J C; Collard P; Bustany P; Comar D; Agid Y
Local cerebral glucose utilisation in treated and untreated patients with Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 1984;47(8):824-30.
1984: Mear J Y; Barroche G; de Smet Y; Weber M; Lhermitte F; Agid Y
Pergolide in the treatment of Parkinson's disease.
Neurology 1984;34(7):983-6.
1984: Mayo W; Dubois B; Ploska A; Javoy-Agid F; Agid Y; Le Moal M; Simon H
Cortical cholinergic projections from the basal forebrain of the rat, with special reference to the prefrontal cortex innervation.
Neuroscience letters 1984;47(2):149-54.
1984: Javoy-Agid F; Ruberg M; Pique L; Bertagna X; Taquet H; Studler J M; Cesselin F; Epelbaum J; Agid Y
Biochemistry of the hypothalamus in Parkinson's disease.
Neurology 1984;34(5):672-5.
1984: Sadoul J L; Kitabgi P; Rostène W; Javoy-Agid F; Agid Y; Vincent J P
Characterization and visualization of neurotensin binding to receptor sites in human brain.
Biochemical and biophysical research communications 1984;120(1):206-13.
1984: Bokobza B; Ruberg M; Scatton B; Javoy-Agid F; Agid Y
[3H]spiperone binding, dopamine and HVA concentrations in Parkinson's disease and supranuclear palsy.
European journal of pharmacology 1984;99(2-3):167-75.
1984: Ruberg M; Bokobza B; Javoy-Agid F; Montfort J C; Agid Y
[3H]spiperone binding in the nigrostriatal system in human brain.
European journal of pharmacology 1984;99(2-3):159-65.
1984: Agid Y; Ploska A; Monfort J C; Javoy-Agid F
Striatal glutamate decarboxylase values, indicative of hospital where patient died.
Lancet 1984;1(8371):280.
1984: Serdaru M; Lacomblez L; Danzé F; Agid Y
[Meningo-myelitis with a favorable course after measles vaccination]
Revue neurologique 1984;140(3):226-7.
1984: Lhermitte F; Agid Y; Serdaru M; Guimaraes J
[Parkinson syndrome, frontal tumor and L-dopa]
Revue neurologique 1984;140(2):138-9.
1984: Agid Y; Ruberg M; Dubois B; Javoy-Agid F
Biochemical substrates of mental disturbances in Parkinson's disease.
Advances in neurology 1984;40():211-8.
1984: Javoy-Agid F; Ruberg M; Taquet H; Bokobza B; Agid Y; Gaspar P; Berger B; N'Guyen-Legros J; Alvarez C; Gray F
Biochemical neuropathology of Parkinson's disease.
Advances in neurology 1984;40():189-98.
1983: Dubois B; Ruberg M; Javoy-Agid F; Ploska A; Agid Y
A subcortico-cortical cholinergic system is affected in Parkinson's disease.
Brain research 1983;288(1-2):213-8.
1983: Taquet H; Javoy-Agid F; Hamon M; Legrand J C; Agid Y; Cesselin F
Parkinson's disease affects differently Met5- and Leu5-enkephalin in the human brain.
Brain research 1983;280(2):379-82.
1983: Pimoule C; Schoemaker H; Javoy-Agid F; Scatton B; Agid Y; Langer S Z
Decrease in [3H]cocaine binding to the dopamine transporter in Parkinson's disease.
European journal of pharmacology 1983;95(1-2):145-6.
1983: Sette M; Ruberg M; Raisman R; Scatton B; Zivkovic B; Agid Y; Langer S Z
[3H]imipramine binding in subcellular fractions of rat cerebral cortex after chemical lesion of serotonergic neurons.
European journal of pharmacology 1983;95(1-2):41-51.
1983: Epelbaum J; Ruberg M; Moyse E; Javoy-Agid F; Dubois B; Agid Y
Somatostatin and dementia in Parkinson's disease.
Brain research 1983;278(1-2):376-9.
1983: Scatton B; Javoy-Agid F; Rouquier L; Dubois B; Agid Y
Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease.
Brain research 1983;275(2):321-8.
1983: Javoy-Agid F; Grouselle D; Tixier-Vidal A; Agid Y
Thyrotropin releasing hormone content is unchanged in brains of patients with Parkinson disease.
Neuropeptides 1983;3(5):405-10.
1983: Jouvent R; Abensour P; Bonnet A M; Widlocher D; Agid Y; Lhermitte F
Antiparkinsonian and antidepressant effects of high doses of bromocriptine. An independent comparison.
Journal of affective disorders 1983;5(2):141-5.
1983: Mauborgne A; Javoy-Agid F; Legrand J C; Agid Y; Cesselin F
Decrease of substance P-like immunoreactivity in the substantia nigra and pallidum of parkinsonian brains.
Brain research 1983;268(1):167-70.
1983: Perry T L; Javoy-Agid F; Agid Y; Fibiger H C
Striatal GABAergic neuronal activity is not reduced in Parkinson's disease.
Journal of neurochemistry 1983;40(4):1120-3.
1983: Gaspar P; Berger B; Gay M; Hamon M; Cesselin F; Vigny A; Javoy-Agid F; Agid Y
Tyrosine hydroxylase and methionine-enkephalin in the human mesencephalon. Immunocytochemical localization and relationships.
Journal of the neurological sciences 1983;58(2):247-67.
1983: Garbarg M; Javoy-Agid F; Schwartz J C; Agid Y
Brain histidine decarboxylase activity in Parkinson's disease.
Lancet 1983;1(8314-5):74-5.
1983: Lloyd K G; De Montis G; Javoy-Agid F; Beaumont K; Lowenthal A; Constantinidis J; Agid Y
Glycine receptors in the human brain: characterization of 3H-strychnine binding and status in pathological conditions.
Advances in biochemical psychopharmacology 1983;36():233-8.
1983: Agid Y; Destee A; Lallemand A
Effect of a methionine-enkephalin analog in Huntington's disease.
Advances in neurology 1983;37():299-304.
1983: Agid Y
[Neurotransmission]
Revue neurologique 1983;139(10):539-45.
1982: de Smet Y; Ruberg M; Serdaru M; Dubois B; Lhermitte F; Agid Y
Confusion, dementia and anticholinergics in Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 1982;45(12):1161-4.
1982: Grove J; Schechter P J; Hanke N F; de Smet Y; Agid Y; Tell G; Koch-Weser J
Concentration gradients of free and total gamma-aminobutyric acid and homocarnosine in human CSF: comparison of suboccipital and lumbar sampling.
Journal of neurochemistry 1982;39(6):1618-22.
1982: Ploska A; Taquet H; Javoy-Agid F; Gaspar P; Cesselin F; Berger B; Hamon M; Legrand J C; Agid Y
Dopamine and methionine-enkephalin in human brain.
Neuroscience letters 1982;33(2):191-6.
1982: Llorens C; Malfroy B; Schwartz J C; Gacel G; Roques B P; Roy J; Morgat J L; Javoy-Agid F; Agid Y
Enkephalin dipeptidyl carboxypeptidase (enkephalinase) activity: selective radioassay, properties, and regional distribution in human brain.
Journal of neurochemistry 1982;39(4):1081-9.
1982: Scatton B; Rouquier L; Javoy-Agid F; Agid Y
Dopamine deficiency in the cerebral cortex in Parkinson disease.
Neurology 1982;32(9):1039-40.
1982: Studler J M; Javoy-Agid F; Cesselin F; Legrand J C; Agid Y
CCK-8-Immunoreactivity distribution in human brain: selective decrease in the substantia nigra from parkinsonian patients.
Brain research 1982;243(1):176-9.
1982: De Smet Y; Mear J Y; Tell G; Schechter P H; Lhermitte F; Agid Y
Effect of gamma-vinyl GABA in Friedreich's ataxia.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1982;9(2):171-3.
1982: Taquet H; Javoy-Agid F; Cesselin F; Hamon M; Legrand J C; Agid Y
Microtopography of methionine-enkephalin, dopamine and noradrenaline in the ventral mesencephalon of human control and Parkinsonian brains.
Brain research 1982;235(2):303-14.
1982: de Montis G; Beaumont K; Javoy-Agid F; Agid Y; Constandinidis J; Lowenthal A; Lloyd K G
Glycine receptors in the human substantia nigra as defined by [3H]strychnine binding.
Journal of neurochemistry 1982;38(3):718-24.
1982: Ruberg M; Ploska A; Javoy-Agid F; Agid Y
Muscarinic binding and choline acetyltransferase activity in Parkinsonian subjects with reference to dementia.
Brain research 1982;232(1):129-39.
1982: Schwartz J C; de la Baume S; Llorens C; Malfroy B; Soroca E; Fournié-Zaluski M C; Roques B P; Morgat J L; Roy J; Javoy-Agid F; Agid Y
Enkephalin dipeptidyl carboxypeptidase ("enkephalinase"): assay, properties, and distribution in human brain and exploration of the active site.
Advances in biochemical psychopharmacology 1982;33():225-34.
1982: Destée A; Petit H; Warot P; Lhermitte F; Agid Y
[Effect of a synthetic analog of enkephalin on the choreic syndrome]
Revue neurologique 1982;138(11):845-9.
1982: Javoy-Agid F; Ruberg M; Taquet H; Studler J M; Garbarg M; Llorens C; Schwartz J C; Grouselle D; Lloyd K G; Raisman R; Agid Y
Biochemical neuroanatomy of the human substantia nigra (pars compacta) in normal and Parkinsonian subjects.
Advances in neurology 1982;35():151-63.
1981: Javoy-Agid F; Ploska A; Agid Y
Microtopography of tyrosine hydroxylase, glutamic acid decarboxylase, and choline acetyltransferase in the substantia nigra and ventral tegmental area of control and Parkinsonian brains.
Journal of neurochemistry 1981;37(5):1218-27.
1981: Langer S Z; Javoy-Agid F; Raisman R; Briley M; Agid Y
Distribution of specific high-affinity binding sites for [3H]imipramine in human brain.
Journal of neurochemistry 1981;37(2):267-71.
1981: Javoy-Agid F; Taquet H; Ploska A; Cherif-Zahar C; Ruberg M; Agid Y
Distribution of catecholamines in the ventral mesencephalon of human brain, with special reference to Parkinson's disease.
Journal of neurochemistry 1981;36(6):2101-5.
1981: Quinn N; Illas A; Lhermitte F; Agid Y
Bromocriptine and domperidone in the treatment of Parkinson disease.
Neurology 1981;31(6):662-7.
1981: Taquet H; Javoy-Agid F; Cesselin F; Agid Y
Methionine-enkephalin deficiency in brains of patients with Parkinson's disease.
Lancet 1981;1(8234):1367-8.
1981: Quinn N; Illas A; Lhermitte F; Agid Y
Bromocriptine in Parkinson's disease: a study of cardiovascular effects.
Journal of neurology, neurosurgery, and psychiatry 1981;44(5):426-9.
1981: Tell G; Böhlen P; Schechter P J; Koch-Weser J; Agid Y; Bonnet A M; Coquillat G; Chazot G; Fischer C
Treatment of Huntington disease with gamma-acetylenic GABA an irreversible inhibitor of GABA-transaminase: increased CSF GABA and homocarnosine without clinical amelioration.
Neurology 1981;31(2):207-11.
1981: Agid Y; Quinn N; Lhermitte F
[Long-term results of treatment of Parkinson's disease with bromocriptine and domperidone (author's transl)]
Revue neurologique 1981;137(1):49-51.
1980: Javoy-Agid F; Agid Y
Is the mesocortical dopaminergic system involved in Parkinson disease?
Neurology 1980;30(12):1326-30.
1980: Barbin G; Palacios J M; Garbarg M; Schwartz J C; Gaspar P; Javoy-Agid F; Agid Y
L-Histidine decarboxylase in the human brain: properties and localization.
Journal of neurochemistry 1980;35(2):400-6.
1980: Böhlen P; Tell G; Schechter P J; Koch-Weser J; Agid Y; Coquillat G; Chazot G; Fischer C
Cerebrospinal fluid homocarnosine in Huntington's disease.
Life sciences 1980;26(13):1009-12.
1980: Gaspar P; Javoy-Agid F; Ploska A; Agid Y
Regional distribution of neurotransmitter synthesizing enzymes in the basal ganglia of human brain.
Journal of neurochemistry 1980;34(2):278-83.
1979: Whiteley A; Signoret J L; Agid Y; Lhermitte F
[Influence of choline on amnesia in Alzheimer's disease (author's transl)]
Revue neurologique 1979;135(8-9):565-72.
1979: Agid Y; Barroche G; Bonnet A M; Javoy-Agid F; Kato G; Lhermitte F; Pollak P; Signoret J L
Dopamine receptor stimulating agonists in the treatment of Parkinson's disease.
Biomedicine / [publiée pour l'A.A.I.C.I.G.] 1979;30(2):67-71.
1979: Kato G; Agid Y
[Acetylcholine receptors (author's transl)]
La Nouvelle presse médicale 1979;8(29):2407-11.
1979: Schwab M E; Otten U; Agid Y; Thoenen H
Nerve growth factor (NGF) in the rat CNS: absence of specific retrograde axonal transport and tyrosine hydroxylase induction in locus coeruleus and substantia nigra.
Brain research 1979;168(3):473-83.
1979: Agid Y; Pollak P; Bonnet A M; Signoret J L; Lhermitte F
Bromocriptine associated with a peripheral dopamine blocking agent in treatment of Parkinson's disease.
Lancet 1979;1(8116):570-2.
1979: Puymirat J; Javoy-Agid F; Gaspar P; Ploska A; Prochiantz A; Agid Y
Post mortem stability and storage in the cold of brain enzymes.
Journal of neurochemistry 1979;32(2):449-54.
1978: Lhermitte F; Signoret J L; Agid Y; Laffont F; Jouvent R
[Treatment of a hallucinatory state with diurnal hypersomnia using oxolinic acid]
La Nouvelle presse médicale 1978;7(43):3936.
1978: Schwab M E; Javoy-Agid F; Agid Y
Labeled wheat germ agglutinin (WGA) as a new, highly sensitive retrograde tracer in the rat brain hippocampal system.
Brain research 1978;152(1):145-50.
1978: Lhermitte F; Agid Y; Signoret J L
Onset and end-of-dose levodopa-induced dyskinesias. Possible treatment by increasing the daily doses of levodopa.
Archives of neurology 1978;35(5):261-3.
1978: Peyrin L; Cottet-Emard J M; Javoy F; Agid Y; Herbet A; Glowinski J
Long-term effects of unilateral 6-hydroxydopamine destruction of the dopaminergic nigrostriatal pathway on the urinary excretion of catecholamines (dopamine, norepinephrine, epinephrine) and their metabolites in the rat.
Brain research 1978;143(3):567-72.
1978: Arluison M; Agid Y; Javoy F
Dopaminergic nerve endings in the neostriatum of the rat--2. Radioautographic study following local micro-injections of tritiated dopamine.
Neuroscience 1978;3(8):675-83.
1978: Arluison M; Agid Y; Javoy F
Dopaminergic nerve endings in the neostriatum of the rat--1. Identification by intracerebral injections of 5-hydroxydopamine.
Neuroscience 1978;3(8):657-73.
1977: Lhermitte F; Agid Y; Feuerstein C; Serre F; Signoret J L; Studler J M; Bonnet A M
[Abnormal movements caused by L-DOPA in patients with Parkinson's disease: correlation with the plasma concentrations of DOPA and O-methyl-DOPA]
Revue neurologique 1977;133(8-9):445-54.
1977: Lhermitte F; Agid Y; Signoret J L; Studler J M
["Beginning and end of dose" dyskinesias caused by L-DOPA]
Revue neurologique 1977;133(5):297-308.
1977: Schwab M; Agid Y; Glowinski J; Thoenen H
Retrograde axonal transport of 125I-tetanus toxin as a tool for tracing fiber connections in the central nervous system; connections of the rostral part of the rat neostriatum.
Brain research 1977;126(2):211-24.
1977: Javoy F; Euvrard C; Herbet A; Bockaert J; Enjalbert A; Agid Y; Glowinski J
Lack of involvement of dopaminergic and GABA neurones in the inhbitory effect of harmaline on the activity of striatal cholinergic neurones in the rat.
Naunyn-Schmiedeberg's archives of pharmacology 1977;297(3):233-9.
1976: Agid Y
[Neurochemical methods]
Revue d'électroencéphalographie et de neurophysiologie clinique 1976;6(4):444-6.
1976: Javoy F; Sotelo C; Herbet A; Agid Y
Specificity of dopaminergic neuronal degeneration induced by intracerebral injection of 6-hydroxydopamine in the nigrostriatal dopamine system.
Brain research 1976;102(2):201-15.
1975: Agid Y
[Neuropharmacologic approach in Huntington's chorea]
Revue neurologique 1975;131(12):847-65.
1975: Javoy F; Agid Y; Glowinski J
Oxotremorine- and atropine-induced changes of dopamine metabolism in the rat striatum.
The Journal of pharmacy and pharmacology 1975;27(9):677-81.
1975: Agid Y; Guyenet P; Glowinski J; Beaujouan J C; Javoy F
Inhibitory influence of the nigrostriatal dopamine system on the striatal cholinergic neurons in the rat.
Brain research 1975;86(3):488-92.
1975: Guyenet P G; Javoy F; Agid Y; Beaujouan J C; Glowinski J
Dopamine receptors and cholinergic neurons in the rat neostriatum.
Advances in neurology 1975;9():43-51.
1974: Agid Y; Javoy F; Glowimski J
Chemical or electrolytic lesion of the substantia nigra: early effects on neostriatal dopamine metabolism.
Brain research 1974;74(1):41-9.
1974: Guyenet P; Agid Y; Javoy F; Beaujouan J C; Glowinski J
[Selective action of neuroleptics on the cholinergic neurons of the neostriatum in the rat: antagonism to apomorphine]
Comptes rendus hebdomadaires des séances de l'Académie des sciences. Série D: Sciences naturelles 1974;278(21):2679-82.
1974: Javoy F; Agid Y; Bouvet D; Glowinski J
Changes in neostriatal DA metabolism after carbachol or atropine microinjections into the substantia nigra.
Brain research 1974;68(2):253-60.
1974: Javoy F; Agid Y; Bouvet D; Glowinski J
In vivo estimation of tyrosine hydroxylation in the dopaminergic terminals of the rat neostriatum.
The Journal of pharmacy and pharmacology 1974;26(3):179-85.
1973: Agid Y; Javoy F; Glowinski J
Hyperactivity of remaining dopaminergic neurones after partial destruction of the nigro-striatal dopaminergic system in the rat.
Nature: New biology 1973;245(144):150-1.
1973: Agid Y; Javoy F; Glowinski J; Bouvet D; Sotelo C
Injection of 6-hydroxydopamine into the substantia nigra of the rat. II. Diffusion and specificity.
Brain research 1973;58(2):291-301.
1973: Sotelo C; Javoy F; Agid Y; Glowinski J
Injection of 6-hydroxydopamine in the substantia nigra of the rat. I. Morphological study.
Brain research 1973;58(2):269-90.
1973: Gauchy C; Agid Y; Glowinski J; Cheramy A
Acute effects of morphine on dopamine synthesis and release and tyrosine metabolism in the rat striatum.
European journal of pharmacology 1973;22(3):311-9.
1973: Agid Y; Javoy F; Youdim M B
Monoamine oxidase and aldehyde dehydrogenase activity in the striatum of rats after 6-hydroxydopamine lesion of the nigrostriatal pathway.
British journal of pharmacology 1973;48(1):175-8.
1973: Javoy F; Youdim M B; Agid Y; Glowinski J
Early effects of monoamine oxidase inhibitors on dopamine metabolism and monoamine oxidase activity in the neostriatum of the rat.
Journal of neural transmission 1973;34(4):279-89.
1972: Javoy F; Agid Y; Bouvet D; Glowinski J
Feedback control of dopamine synthesis in dopaminergic terminals of the rat striatum.
The Journal of pharmacology and experimental therapeutics 1972;182(3):454-63.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Yves Agid

Research Profile (preview)

Disorders

Anatomy

Chemicals & Drugs

Living Beings

Concepts & Ideas

Procedures

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Yves Agid (preview)

All Publications